| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.12e-11 | 25 | 156 | 8 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.21e-09 | 27 | 156 | 7 | GO:0008139 | |
| GeneOntologyMolecularFunction | signal sequence binding | 1.35e-07 | 51 | 156 | 7 | GO:0005048 | |
| GeneOntologyMolecularFunction | chromatin binding | ASXL1 TCF3 ZEB1 ASH1L GATA2 NUP98 KDM3B MLLT10 PHF8 TRIM24 TRIM66 SETDB1 EGR1 TRIM28 MCM3AP VAX2 DLX2 MBD5 POLQ HCFC1 NUP153 | 3.20e-07 | 739 | 156 | 21 | GO:0003682 |
| GeneOntologyMolecularFunction | protein domain specific binding | EVL CACNB2 TCF3 TCF12 UBQLN1 SCAF8 NCKIPSD GATA2 ARHGAP17 GRIA1 IRS1 DNAJC6 PIAS1 SCAF1 MAVS TRIM28 IRS2 TACC3 CDC25C OLIG2 PROX1 | 4.71e-06 | 875 | 156 | 21 | GO:0019904 |
| GeneOntologyMolecularFunction | RNA polymerase binding | 1.17e-05 | 65 | 156 | 6 | GO:0070063 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TBX22 ZNF536 TCF3 ZEB1 TCF12 YY2 GATA2 LHX3 RREB1 RFX7 TRIM24 TFCP2 SP8 PER2 EGR1 ZNF408 VAX2 ELF3 DLX2 TBX20 MUC1 OLIG2 HCFC1 PROX1 | 3.61e-05 | 1244 | 156 | 24 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TBX22 ZNF536 TCF3 ZEB1 TCF12 YY2 GATA2 LHX3 RREB1 RFX7 TRIM24 TFCP2 SP8 PER2 EGR1 ZNF408 VAX2 ELF3 DLX2 TBX20 MUC1 OLIG2 HCFC1 PROX1 | 5.08e-05 | 1271 | 156 | 24 | GO:0000987 |
| GeneOntologyMolecularFunction | kinase binding | CACNB2 TCF3 CHIA UBQLN1 GRIA1 CASR IRS1 DCTN1 ZFP36 MAP3K1 MAPK8IP3 LATS1 PER3 PER2 MAVS DACT3 IRS2 FCRL5 CDC25C RAD23A | 6.91e-05 | 969 | 156 | 20 | GO:0019900 |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 7.37e-05 | 11 | 156 | 3 | GO:0099122 | |
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 9.72e-05 | 59 | 156 | 5 | GO:0031593 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 3.18e-04 | 42 | 156 | 4 | GO:0140693 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | TBX22 ZNF536 TCF3 ZEB1 TCF12 YY2 GATA2 LHX3 RREB1 RFX7 TRIM24 TFCP2 SP8 PER2 EGR1 ZNF408 VAX2 ELF3 DLX2 TBX20 MUC1 OLIG2 HCFC1 PROX1 | 4.09e-04 | 1459 | 156 | 24 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 4.16e-04 | 45 | 156 | 4 | GO:0043175 | |
| GeneOntologyMolecularFunction | histone H3K9me/H3K9me2 demethylase activity | 5.97e-04 | 5 | 156 | 2 | GO:0140683 | |
| GeneOntologyMolecularFunction | transcription factor binding | ASXL1 TCF3 TCF12 GATA2 LHX3 TRIM24 PIAS1 TFCP2 LATS1 PER3 PER2 BSN TBX20 HCFC1 PROX1 | 8.41e-04 | 753 | 156 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | peptide binding | 9.08e-04 | 318 | 156 | 9 | GO:0042277 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.20e-03 | 206 | 156 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | E-box binding | 1.32e-03 | 61 | 156 | 4 | GO:0070888 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | ASXL1 NUP98 KDM3B PHF8 SRCAP TRIM24 PIAS1 PER2 TRIM28 MED26 MUC1 HCFC1 | 1.57e-03 | 562 | 156 | 12 | GO:0003712 |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 1.65e-03 | 8 | 156 | 2 | GO:0140948 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | ASXL1 UBQLN2 STON1 NUP98 KDM3B IRS1 PHF8 SRCAP TRIM24 PIAS1 MAPK8IP3 PER2 MAVS TRIM28 IRS2 MED26 MUC1 HCFC1 NUP153 | 1.80e-03 | 1160 | 156 | 19 | GO:0030674 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | ASXL1 TCF3 TCF12 GATA2 LHX3 TRIM24 PIAS1 LATS1 PER2 TBX20 HCFC1 PROX1 | 2.10e-03 | 582 | 156 | 12 | GO:0140297 |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase activator activity | 2.11e-03 | 9 | 156 | 2 | GO:0141038 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 2.62e-03 | 10 | 156 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | K48-linked polyubiquitin modification-dependent protein binding | 2.62e-03 | 10 | 156 | 2 | GO:0036435 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.68e-03 | 303 | 156 | 8 | GO:0003713 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 3.67e-09 | 18 | 162 | 6 | GO:0006999 | |
| GeneOntologyBiologicalProcess | mRNA transport | NUP98 NUP214 NUP42 NUP58 POM121C ZFP36 NUP54 POM121 MCM3AP POM121B NUP153 | 2.04e-08 | 145 | 162 | 11 | GO:0051028 |
| GeneOntologyBiologicalProcess | RNA transport | NUP98 NUP214 NUP42 NUP58 POM121C ZFP36 NUP54 POM121 MCM3AP POM121B NUP153 | 1.41e-07 | 175 | 162 | 11 | GO:0050658 |
| GeneOntologyBiologicalProcess | nucleic acid transport | NUP98 NUP214 NUP42 NUP58 POM121C ZFP36 NUP54 POM121 MCM3AP POM121B NUP153 | 1.41e-07 | 175 | 162 | 11 | GO:0050657 |
| GeneOntologyBiologicalProcess | establishment of RNA localization | NUP98 NUP214 NUP42 NUP58 POM121C ZFP36 NUP54 POM121 MCM3AP POM121B NUP153 | 1.68e-07 | 178 | 162 | 11 | GO:0051236 |
| GeneOntologyBiologicalProcess | protein import into nucleus | FAM53A NUP98 NUP214 NUP58 POM121C NUP54 POM121 MAVS TRIM28 POM121B NUP153 | 4.20e-07 | 195 | 162 | 11 | GO:0006606 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TBX22 RBM15 ZNF536 TCF3 ZEB1 SCAF8 TRO GATA2 RREB1 ZHX2 TRIM24 PIAS1 ZFP36 ZNF503 TRIM66 SETDB1 PER3 PER2 MAGED4 EGR1 TRIM28 VAX2 ELF3 DLX2 TBX20 MUC1 OLIG2 HCFC1 DNMT3L PROX1 | 4.28e-07 | 1399 | 162 | 30 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TBX22 RBM15 ZNF536 TCF3 ZEB1 SCAF8 TRO GATA2 RREB1 ZHX2 TRIM24 PIAS1 ZFP36 ZNF503 TRIM66 SETDB1 PER3 PER2 MAGED4 EGR1 TRIM28 VAX2 ELF3 DLX2 TBX20 MUC1 OLIG2 HCFC1 DNMT3L PROX1 | 5.29e-07 | 1413 | 162 | 30 | GO:1902679 |
| GeneOntologyBiologicalProcess | import into nucleus | FAM53A NUP98 NUP214 NUP58 POM121C NUP54 POM121 MAVS TRIM28 POM121B NUP153 | 5.67e-07 | 201 | 162 | 11 | GO:0051170 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TBX22 RBM15 ZNF536 TCF3 ZEB1 SCAF8 TRO GATA2 RREB1 ZHX2 PIAS1 ZFP36 SETDB1 PER3 PER2 MAGED4 EGR1 TRIM28 VAX2 DLX2 TBX20 OLIG2 HCFC1 DNMT3L PROX1 | 7.31e-07 | 1053 | 162 | 25 | GO:0000122 |
| GeneOntologyBiologicalProcess | RNA localization | NUP98 NUP214 NUP42 NUP58 POM121C ZFP36 NUP54 POM121 MCM3AP POM121B NUP153 | 1.21e-06 | 217 | 162 | 11 | GO:0006403 |
| GeneOntologyBiologicalProcess | immunoglobulin production | TCF3 IGLV4-60 IGLV3-19 MCM3AP IGKV6D-21 IGKV3D-20 POLQ IGKV6-21 IGKV4-1 IGKV3-20 IGKV3-7 | 3.35e-06 | 241 | 162 | 11 | GO:0002377 |
| GeneOntologyBiologicalProcess | spinal cord development | 4.56e-06 | 119 | 162 | 8 | GO:0021510 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | NUP98 NUP214 NUP42 NUP58 POM121C ZFP36 NUP54 POM121 MCM3AP POM121B NUP153 | 4.58e-06 | 249 | 162 | 11 | GO:0015931 |
| GeneOntologyBiologicalProcess | ventral spinal cord development | 5.58e-06 | 57 | 162 | 6 | GO:0021517 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | FAM53A NUP98 IRS1 NUP214 NUP58 POM121C NUP54 LATS1 POM121 MAVS TRIM28 POM121B NUP153 | 5.96e-06 | 362 | 162 | 13 | GO:0034504 |
| GeneOntologyBiologicalProcess | nucleus organization | 8.16e-06 | 170 | 162 | 9 | GO:0006997 | |
| GeneOntologyBiologicalProcess | nuclear transport | FAM53A NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MAVS TRIM28 MCM3AP POM121B NUP153 | 9.48e-06 | 378 | 162 | 13 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | FAM53A NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MAVS TRIM28 MCM3AP POM121B NUP153 | 9.48e-06 | 378 | 162 | 13 | GO:0006913 |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 1.07e-05 | 96 | 162 | 7 | GO:0006405 | |
| GeneOntologyBiologicalProcess | production of molecular mediator of immune response | TCF3 ASH1L IGLV4-60 IGLV3-19 MAVS MCM3AP IGKV6D-21 IGKV3D-20 POLQ IGKV6-21 IGKV4-1 IGKV3-20 IGKV3-7 | 1.87e-05 | 403 | 162 | 13 | GO:0002440 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ASXL1 RBM15 TCF3 ZEB1 TCF12 ASH1L YY2 GATA2 LHX3 MLLT10 PHF8 RREB1 RFX7 TFCP2 MAP3K1 TFR2 MAVS EGR1 ELF3 DLX2 MED26 TBX20 MUC1 OLIG2 HCFC1 PROX1 | 3.14e-05 | 1390 | 162 | 26 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of heterochromatin formation | 3.45e-05 | 24 | 162 | 4 | GO:0031445 | |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | 3.49e-05 | 255 | 162 | 10 | GO:0045664 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron differentiation | 5.36e-05 | 123 | 162 | 7 | GO:0045666 | |
| GeneOntologyBiologicalProcess | nuclear export | 1.10e-04 | 185 | 162 | 8 | GO:0051168 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of DNA-templated transcription | 1.83e-04 | 3 | 162 | 2 | GO:0060567 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | FAM53A NUP98 NUP214 NUP42 NUP58 POM121C MAPK8IP3 NUP54 POM121 MAVS TRIM28 SEC23IP KIF5A SYVN1 POM121B NUP153 | 2.46e-04 | 740 | 162 | 16 | GO:0006886 |
| GeneOntologyBiologicalProcess | chromatin remodeling | RBM15 TCF3 SMARCAL1 ASH1L KDM3B PHF8 SRCAP EZHIP SETDB1 PER2 EGR1 TRIM28 MCM3AP SPTY2D1 HCFC1 DNMT3L | 2.50e-04 | 741 | 162 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 2.69e-04 | 40 | 162 | 4 | GO:1902275 | |
| GeneOntologyBiologicalProcess | axonal transport | 3.11e-04 | 75 | 162 | 5 | GO:0098930 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | ASXL1 RBM15 TCF3 SMARCAL1 ASH1L KDM3B PHF8 SRCAP PIAS1 EZHIP SETDB1 PER2 EGR1 TRIM28 MCM3AP MED26 SPTY2D1 HCFC1 DNMT3L | 3.28e-04 | 999 | 162 | 19 | GO:0071824 |
| GeneOntologyBiologicalProcess | forebrain development | ZEB1 GATA2 GRIA1 SRGAP2 LHX3 MAPK8IP3 VAX2 TMEM108 DLX2 TACC3 OLIG2 PROX1 | 4.99e-04 | 489 | 162 | 12 | GO:0030900 |
| GeneOntologyCellularComponent | nuclear pore | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MCM3AP POM121B NUP153 | 6.20e-09 | 101 | 162 | 10 | GO:0005643 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ASXL1 TCF3 TCF12 INTS12 AFF2 SCAF8 SMARCAL1 UBQLN4 NCKIPSD YY2 NUP98 KDM3B NUP214 NUP42 NUP58 SRCAP POM121C NUP54 POM121 PER2 TRIM28 CLMN MCM3AP CCNL1 BOD1L1 MED26 POM121B HCFC1 NUP153 AFF4 DNMT3L | 6.71e-08 | 1377 | 162 | 31 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear membrane | RBM15 NUP98 NUP42 NUP58 PHF8 POM121C NUP54 POM121 CLMN MCM3AP NAV3 POM121B NUP153 | 3.48e-06 | 349 | 162 | 13 | GO:0031965 |
| GeneOntologyCellularComponent | chromatin | TBX22 TCF3 ZEB1 TCF12 YY2 KDM3B LHX3 SRCAP RFX7 ZHX2 TRIM24 PIAS1 TFCP2 TRIM66 SP8 EGR1 TRIM28 VAX2 ELF3 DLX2 TBX20 MUC1 OLIG2 HCFC1 AFF4 DNMT3L PROX1 | 2.66e-05 | 1480 | 162 | 27 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear envelope | RBM15 NUP98 NUP214 NUP42 NUP58 PHF8 POM121C DCTN1 NUP54 POM121 CLMN MCM3AP NAV3 POM121B NUP153 | 3.18e-05 | 560 | 162 | 15 | GO:0005635 |
| GeneOntologyCellularComponent | immunoglobulin complex | IGLV4-60 IGLV3-19 IGKV6D-21 IGKV3D-20 IGKV6-21 IGKV4-1 IGKV3-20 IGKV3-7 | 4.68e-05 | 166 | 162 | 8 | GO:0019814 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.42e-04 | 18 | 162 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | super elongation complex | 8.77e-04 | 6 | 162 | 2 | GO:0032783 | |
| Domain | Znf_FYVE_PHD | INTS12 ASH1L MLLT10 PHF8 TRIM24 ZFYVE28 TRIM66 TRIM28 BSN DNMT3L | 3.07e-07 | 147 | 150 | 10 | IPR011011 |
| Domain | Znf_PHD | 6.95e-07 | 91 | 150 | 8 | IPR001965 | |
| Domain | STI1 | 8.08e-07 | 10 | 150 | 4 | SM00727 | |
| Domain | STI1_HS-bd | 8.08e-07 | 10 | 150 | 4 | IPR006636 | |
| Domain | Zinc_finger_PHD-type_CS | 8.83e-07 | 65 | 150 | 7 | IPR019786 | |
| Domain | ZF_PHD_2 | 9.67e-07 | 95 | 150 | 8 | PS50016 | |
| Domain | ZF_PHD_1 | 1.05e-06 | 96 | 150 | 8 | PS01359 | |
| Domain | PHD | 2.35e-06 | 75 | 150 | 7 | PF00628 | |
| Domain | Znf_PHD-finger | 3.35e-06 | 79 | 150 | 7 | IPR019787 | |
| Domain | - | INTS12 ASH1L COP1 MLLT10 PHF8 TRIM24 ZNRF2 MAP3K1 ZFYVE28 TRIM66 TRIM28 SYVN1 BSN MEX3B DNMT3L | 3.44e-06 | 449 | 150 | 15 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | INTS12 ASH1L COP1 MLLT10 PHF8 TRIM24 ZNRF2 MAP3K1 ZFYVE28 TRIM66 TRIM28 SYVN1 BSN MEX3B DNMT3L | 4.49e-06 | 459 | 150 | 15 | IPR013083 |
| Domain | PHD | 7.44e-06 | 89 | 150 | 7 | SM00249 | |
| Domain | UBA | 9.64e-06 | 36 | 150 | 5 | PF00627 | |
| Domain | Ubiquilin | 9.98e-06 | 6 | 150 | 3 | IPR015496 | |
| Domain | UBA | 2.64e-05 | 44 | 150 | 5 | IPR015940 | |
| Domain | UBA | 3.65e-05 | 47 | 150 | 5 | PS50030 | |
| Domain | AT_hook | 6.07e-05 | 27 | 150 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 6.07e-05 | 27 | 150 | 4 | IPR017956 | |
| Domain | Ubiquilin-1/2 | 6.41e-05 | 2 | 150 | 2 | IPR028430 | |
| Domain | PTBI | 7.99e-05 | 11 | 150 | 3 | SM00310 | |
| Domain | UBA | 9.31e-05 | 30 | 150 | 4 | SM00165 | |
| Domain | IRS_PTB | 1.06e-04 | 12 | 150 | 3 | PS51064 | |
| Domain | DUF4599 | 1.06e-04 | 12 | 150 | 3 | PF15371 | |
| Domain | DUF4599 | 1.06e-04 | 12 | 150 | 3 | IPR027970 | |
| Domain | UBA-like | 1.63e-04 | 64 | 150 | 5 | IPR009060 | |
| Domain | IRS | 1.73e-04 | 14 | 150 | 3 | PF02174 | |
| Domain | IRS_PTB | 1.73e-04 | 14 | 150 | 3 | IPR002404 | |
| Domain | Period_circadian-like_C | 1.91e-04 | 3 | 150 | 2 | IPR022728 | |
| Domain | Period_C | 1.91e-04 | 3 | 150 | 2 | PF12114 | |
| Domain | UBIQUITIN_1 | 2.15e-04 | 37 | 150 | 4 | PS00299 | |
| Domain | BROMODOMAIN_1 | 2.15e-04 | 37 | 150 | 4 | PS00633 | |
| Domain | Bbox_C | 2.15e-04 | 15 | 150 | 3 | IPR003649 | |
| Domain | BBC | 2.15e-04 | 15 | 150 | 3 | SM00502 | |
| Domain | BROMODOMAIN_2 | 3.21e-04 | 41 | 150 | 4 | PS50014 | |
| Domain | Bromodomain | 3.53e-04 | 42 | 150 | 4 | IPR001487 | |
| Domain | BROMO | 3.53e-04 | 42 | 150 | 4 | SM00297 | |
| Domain | - | 3.53e-04 | 42 | 150 | 4 | 1.20.920.10 | |
| Domain | TF_AF4/FMR2 | 3.80e-04 | 4 | 150 | 2 | IPR007797 | |
| Domain | AF-4 | 3.80e-04 | 4 | 150 | 2 | PF05110 | |
| Domain | UBQ | 3.87e-04 | 43 | 150 | 4 | SM00213 | |
| Domain | 6-PGluconate_DH_C-like | 4.48e-04 | 19 | 150 | 3 | IPR008927 | |
| Domain | ubiquitin | 5.45e-04 | 47 | 150 | 4 | PF00240 | |
| Domain | SEA | 6.99e-04 | 22 | 150 | 3 | PF01390 | |
| Domain | SEA | 7.99e-04 | 23 | 150 | 3 | PS50024 | |
| Domain | SEA_dom | 7.99e-04 | 23 | 150 | 3 | IPR000082 | |
| Domain | UBIQUITIN_2 | 9.25e-04 | 54 | 150 | 4 | PS50053 | |
| Domain | Ubiquitin_dom | 1.21e-03 | 58 | 150 | 4 | IPR000626 | |
| Domain | RNA_pol_II-bd | 1.31e-03 | 7 | 150 | 2 | IPR006903 | |
| Domain | CTD_bind | 1.31e-03 | 7 | 150 | 2 | PF04818 | |
| Domain | RPR | 1.74e-03 | 8 | 150 | 2 | SM00582 | |
| Domain | PTEN_C2 | 1.74e-03 | 8 | 150 | 2 | PF10409 | |
| Domain | CID_dom | 1.74e-03 | 8 | 150 | 2 | IPR006569 | |
| Domain | PTEN_C2 | 1.74e-03 | 8 | 150 | 2 | SM01326 | |
| Domain | C2_TENSIN | 1.74e-03 | 8 | 150 | 2 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 1.74e-03 | 8 | 150 | 2 | IPR029023 | |
| Domain | CID | 1.74e-03 | 8 | 150 | 2 | PS51391 | |
| Domain | Tensin_C2-dom | 1.74e-03 | 8 | 150 | 2 | IPR014020 | |
| Domain | CH | 1.85e-03 | 65 | 150 | 4 | SM00033 | |
| Domain | PPASE_TENSIN | 2.22e-03 | 9 | 150 | 2 | PS51181 | |
| Domain | CH | 2.43e-03 | 70 | 150 | 4 | PF00307 | |
| Domain | - | 2.56e-03 | 71 | 150 | 4 | 1.10.418.10 | |
| Domain | CH | 2.83e-03 | 73 | 150 | 4 | PS50021 | |
| Domain | CH-domain | 3.12e-03 | 75 | 150 | 4 | IPR001715 | |
| Domain | MBD | 3.36e-03 | 11 | 150 | 2 | SM00391 | |
| Domain | MBD | 3.36e-03 | 11 | 150 | 2 | PS50982 | |
| Domain | Methyl_CpG_DNA-bd | 3.36e-03 | 11 | 150 | 2 | IPR001739 | |
| Domain | MBD | 3.36e-03 | 11 | 150 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 3.36e-03 | 11 | 150 | 2 | IPR016177 | |
| Domain | Bromodomain | 3.49e-03 | 38 | 150 | 3 | PF00439 | |
| Domain | OLF | 4.72e-03 | 13 | 150 | 2 | PF02191 | |
| Domain | OLF | 4.72e-03 | 13 | 150 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 4.72e-03 | 13 | 150 | 2 | IPR003112 | |
| Domain | OLF | 4.72e-03 | 13 | 150 | 2 | SM00284 | |
| Domain | Homeodomain-like | 5.45e-03 | 332 | 150 | 8 | IPR009057 | |
| Domain | SEA | 5.47e-03 | 14 | 150 | 2 | SM00200 | |
| Domain | - | 6.28e-03 | 15 | 150 | 2 | 3.30.70.960 | |
| Domain | Post-SET_dom | 7.14e-03 | 16 | 150 | 2 | IPR003616 | |
| Domain | PostSET | 7.14e-03 | 16 | 150 | 2 | SM00508 | |
| Domain | VWF_type-D | 7.14e-03 | 16 | 150 | 2 | IPR001846 | |
| Domain | VWFD | 7.14e-03 | 16 | 150 | 2 | PS51233 | |
| Domain | VWD | 7.14e-03 | 16 | 150 | 2 | SM00216 | |
| Domain | POST_SET | 7.14e-03 | 16 | 150 | 2 | PS50868 | |
| Domain | VWD | 7.14e-03 | 16 | 150 | 2 | PF00094 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | NUP98 NUP214 NUP42 NUP58 POM121C PIAS1 NUP54 POM121 POM121B NUP153 | 3.85e-12 | 47 | 116 | 10 | MM14939 |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.18e-11 | 39 | 116 | 9 | M27238 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 2.79e-11 | 40 | 116 | 9 | MM14945 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 3.55e-11 | 41 | 116 | 9 | MM15200 |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 4.49e-11 | 42 | 116 | 9 | MM15039 |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 5.63e-11 | 43 | 116 | 9 | MM14609 |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | NUP98 NUP214 NUP42 NUP58 POM121C PIAS1 NUP54 POM121 POM121B NUP153 | 1.18e-10 | 65 | 116 | 10 | MM15147 |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 1.47e-10 | 32 | 116 | 8 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 1.93e-10 | 33 | 116 | 8 | M27016 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 1.97e-10 | 49 | 116 | 9 | MM14837 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 2.39e-10 | 50 | 116 | 9 | MM14610 |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 2.50e-10 | 34 | 116 | 8 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 2.88e-10 | 51 | 116 | 9 | MM15151 |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 3.22e-10 | 35 | 116 | 8 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.11e-10 | 36 | 116 | 8 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.11e-10 | 36 | 116 | 8 | M27245 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 5.21e-10 | 37 | 116 | 8 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 5.21e-10 | 37 | 116 | 8 | M27038 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 5.85e-10 | 55 | 116 | 9 | MM14917 |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 9.60e-10 | 58 | 116 | 9 | MM15149 |
| Pathway | REACTOME_SNRNP_ASSEMBLY | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 9.60e-10 | 58 | 116 | 9 | MM14736 |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 1.25e-09 | 41 | 116 | 8 | M29574 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | NUP98 NUP214 NUP42 NUP58 POM121C PIAS1 NUP54 POM121 POM121B NUP153 | 1.59e-09 | 84 | 116 | 10 | MM14929 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.88e-09 | 43 | 116 | 8 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 2.28e-09 | 44 | 116 | 8 | M109 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 3.31e-09 | 46 | 116 | 8 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 3.96e-09 | 47 | 116 | 8 | M27395 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 6.14e-09 | 71 | 116 | 9 | M27394 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 7.90e-09 | 73 | 116 | 9 | MM14948 |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.07e-08 | 53 | 116 | 8 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.25e-08 | 54 | 116 | 8 | M29594 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.28e-08 | 77 | 116 | 9 | M27226 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 2.24e-08 | 82 | 116 | 9 | MM15394 |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 2.58e-08 | 59 | 116 | 8 | M27606 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 3.42e-08 | 86 | 116 | 9 | MM15413 |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 6.20e-08 | 92 | 116 | 9 | MM14951 |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 1.58e-07 | 74 | 116 | 8 | M48006 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.54e-07 | 82 | 116 | 8 | M27250 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 3.98e-07 | 114 | 116 | 9 | MM15361 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 4.27e-07 | 84 | 116 | 8 | M725 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 4.68e-07 | 85 | 116 | 8 | M1870 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 9.31e-07 | 126 | 116 | 9 | M45009 | |
| Pathway | REACTOME_SUMOYLATION | NUP98 NUP214 NUP42 NUP58 POM121C PIAS1 NUP54 POM121 POM121B NUP153 | 1.28e-06 | 169 | 116 | 10 | MM14919 |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 1.51e-06 | 99 | 116 | 8 | M27474 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.76e-06 | 101 | 116 | 8 | M27253 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 2.00e-06 | 138 | 116 | 9 | M29805 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 2.53e-06 | 142 | 116 | 9 | M27660 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.54e-06 | 106 | 116 | 8 | M27458 | |
| Pathway | REACTOME_SUMOYLATION | NUP98 NUP214 NUP42 NUP58 POM121C PIAS1 NUP54 POM121 TRIM28 NUP153 | 3.53e-06 | 189 | 116 | 10 | M27214 |
| Pathway | REACTOME_TRNA_PROCESSING | 3.60e-06 | 111 | 116 | 8 | M27684 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 4.20e-06 | 151 | 116 | 9 | M550 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | 5.00e-06 | 116 | 116 | 8 | M29806 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 7.34e-06 | 16 | 116 | 4 | M27410 | |
| Pathway | REACTOME_HCMV_INFECTION | 7.47e-06 | 162 | 116 | 9 | M29804 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 9.54e-06 | 17 | 116 | 4 | M27412 | |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 1.23e-05 | 131 | 116 | 8 | M5283 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | NUP98 NUP214 NUP42 NUP58 POM121C PIAS1 NUP54 POM121 MAVS EGR1 NUP153 | 1.53e-05 | 273 | 116 | 11 | M983 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.89e-05 | 139 | 116 | 8 | M715 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.34e-05 | 21 | 116 | 4 | MM15706 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 3.13e-05 | 149 | 116 | 8 | M4076 | |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | 3.18e-05 | 109 | 116 | 7 | M39542 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.42e-05 | 23 | 116 | 4 | M556 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 4.07e-05 | 24 | 116 | 4 | MM15658 | |
| Pathway | REACTOME_INFLUENZA_INFECTION | 4.55e-05 | 157 | 116 | 8 | M4669 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 4.68e-05 | 204 | 116 | 9 | M45011 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 5.66e-05 | 26 | 116 | 4 | M27483 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 6.60e-05 | 27 | 116 | 4 | M29807 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 1.01e-04 | 30 | 116 | 4 | M47752 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 1.06e-04 | 177 | 116 | 8 | M27476 | |
| Pathway | WP_PREIMPLANTATION_EMBRYO | 1.22e-04 | 59 | 116 | 5 | M39579 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 IGLV3-19 POM121 MAVS IGKV3D-20 IGKV4-1 IGKV3-20 NUP153 | 1.31e-04 | 471 | 116 | 13 | M39009 |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | TCF3 TCF12 INTS12 GATA2 NUP98 NUP214 NUP42 NUP58 POM121C NUP54 SETDB1 POM121 TRIM28 RPRD2 BOD1L1 CDC25C POM121B HCFC1 NUP153 AFF4 | 2.36e-04 | 1022 | 116 | 20 | MM15436 |
| Pathway | PID_SMAD2_3PATHWAY | 2.81e-04 | 16 | 116 | 3 | M228 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ASXL1 NUP98 COP1 MUC16 GRIA1 NUP214 MUC12 NUP42 NUP58 POM121C DCTN1 PIAS1 NUP54 CCNF POM121 MAVS TRIM28 SEC23IP SYVN1 MBD5 MUC1 MUC4 HCFC1 NUP153 RAD23A | 3.36e-04 | 1475 | 116 | 25 | M19806 |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 3.99e-04 | 271 | 116 | 9 | MM15406 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 4.67e-04 | 277 | 116 | 9 | MM15414 |
| Pathway | REACTOME_HIV_INFECTION | 6.41e-04 | 231 | 116 | 8 | M12469 | |
| Pathway | REACTOME_IRS_ACTIVATION | 6.61e-04 | 5 | 116 | 2 | M27707 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | ZEB1 NUP98 IRS1 NUP214 NUP42 NUP58 POM121C PIAS1 NUP54 POM121 EDAR MAVS EGR1 IRS2 MUC1 NUP153 | 7.24e-04 | 789 | 116 | 16 | M1060 |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 7.47e-04 | 87 | 116 | 5 | M27205 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 8.08e-04 | 299 | 116 | 9 | M41727 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ASXL1 NUP98 MUC19 COP1 MUC16 GRIA1 NUP214 NUP42 NUP58 POM121C DCTN1 PIAS1 NUP54 CCNF POM121 SEC23IP MBD5 MUC1 POM121B MUC4 HCFC1 NUP153 RAD23A | 8.39e-04 | 1389 | 116 | 23 | MM15307 |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | EGLN2 NUP98 NUP214 NUP42 NUP58 POM121C DCTN1 NUP54 POM121 POM121B MAP4K4 NUP153 | 9.16e-04 | 505 | 116 | 12 | MM15548 |
| Pathway | WP_INTERFERON_TYPE_I_SIGNALING | 1.00e-03 | 54 | 116 | 4 | M39435 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 1.23e-03 | 26 | 116 | 3 | M47923 | |
| Pathway | REACTOME_M_PHASE | NUP98 NUP214 NUP42 NUP58 POM121C DCTN1 NUP54 POM121 POM121B NUP153 | 1.33e-03 | 387 | 116 | 10 | MM15364 |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 1.37e-03 | 7 | 116 | 2 | M19489 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.49e-03 | 60 | 116 | 4 | MM15636 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 1.58e-03 | 61 | 116 | 4 | M27581 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.68e-03 | 62 | 116 | 4 | M546 | |
| Pathway | REACTOME_M_PHASE | NUP98 NUP214 NUP42 NUP58 PHF8 POM121C DCTN1 NUP54 POM121 NUP153 | 2.31e-03 | 417 | 116 | 10 | M27662 |
| Pathway | REACTOME_PI3K_AKT_ACTIVATION | 2.33e-03 | 9 | 116 | 2 | M714 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.34e-03 | 283 | 116 | 8 | M13087 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.36e-03 | 68 | 116 | 4 | M27303 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.36e-03 | 68 | 116 | 4 | MM14921 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.49e-03 | 69 | 116 | 4 | M27108 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 2.49e-03 | 69 | 116 | 4 | M27150 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.61e-03 | 288 | 116 | 8 | M16864 | |
| Pathway | REACTOME_PARASITE_INFECTION | 2.69e-03 | 116 | 116 | 5 | M29843 | |
| Pathway | PID_ATM_PATHWAY | 2.70e-03 | 34 | 116 | 3 | M84 | |
| Pubmed | KRT5 NUP98 ARHGAP17 NCKAP5 NUP214 MUC12 NUP42 NUP58 POM121C DCTN1 PIAS1 NUP54 SETDB1 LATS1 POM121 EGR1 TRIM28 MCM3AP NAV3 NAV2 MACF1 KIF5A MBD5 MAP3K21 MUC1 MAP4K4 TNS1 NUP153 | 1.95e-22 | 486 | 162 | 28 | 20936779 | |
| Pubmed | ASXL1 ZNF536 SCAF8 TRO SPEG NUP214 PHF8 ZHX2 DNAJC6 SETDB1 PER2 MCM3AP NAV3 MACF1 BOD1L1 SYVN1 ADGRL3 PRRC2B PDZD2 | 7.43e-14 | 407 | 162 | 19 | 12693553 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 1.20e-13 | 38 | 162 | 9 | 12791264 |
| Pubmed | ASXL1 ZNF536 TCF3 ZEB1 TCF12 INTS12 ATXN7L1 SCAF8 YY2 GATA2 NUP98 MSANTD2 COP1 NUP214 LHX3 MLLT10 PHF8 RREB1 SRCAP RFX7 ZHX2 POM121C TRIM24 PIAS1 TFCP2 ZNF503 NUP54 SETDB1 ELF3 RPRD2 HCFC1 PRRC2B | 1.29e-13 | 1429 | 162 | 32 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPEG SIPA1L3 GATA2 KDM3B ARHGAP17 IRS1 SRGAP2 NUP214 CACFD1 MLLT10 SRCAP POM121C DCTN1 MAPK8IP3 ZNF503 SCAF1 PER2 TRIM28 ZNF408 MCM3AP NAV2 DLX2 IRS2 SYVN1 MBD5 HCFC1 PRRC2B | 1.84e-12 | 1105 | 162 | 27 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | UBQLN2 UBQLN1 AFF2 SPATA31E1 TRO NUP98 NUP214 MLLT10 POM121C PIAS1 MAP3K1 LATS1 POM121 EGR1 BSN MEX3B ADGRL3 NUP153 | 2.17e-12 | 430 | 162 | 18 | 35044719 |
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | NUP98 NUP214 NUP42 NUP58 NUP54 POM121 MAVS MCM3AP NUP153 PDZD2 | 3.05e-12 | 77 | 162 | 10 | 24927568 |
| Pubmed | 2.55e-11 | 26 | 162 | 7 | 12228227 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RBM15 INTS12 SIPA1L3 NCKIPSD KDM3B ARHGAP17 IRS1 SRGAP2 PLEKHG2 RFX7 ZNRF2 LATS1 CLMN NAV2 MACF1 BOD1L1 IRS2 MAP3K21 CDC25C MAP4K4 MEX3B SAMD4A | 1.09e-10 | 861 | 162 | 22 | 36931259 |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF536 ZEB1 NUP98 NUP214 NUP58 RREB1 RFX7 ZHX2 POM121C TRIM24 PIAS1 ZNF503 NUP54 MCM3AP PRRC2B | 1.22e-10 | 351 | 162 | 15 | 38297188 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | ASH1L NUP98 MUC19 NUP214 NUP42 POM121C MAVS HCFC1 NUP153 PDZD2 | 3.47e-10 | 123 | 162 | 10 | 26912792 |
| Pubmed | CACNB2 ZEB1 SIPA1L3 MSANTD2 GRIA1 SRGAP2 DNAJC6 DCTN1 MAPK8IP3 CAMKV TRIM28 SEC23IP MACF1 KIF5A TACC3 BSN MAP4K4 TNS1 NUP153 AFF4 PRRC2B PROX1 | 8.84e-10 | 963 | 162 | 22 | 28671696 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | TCF3 SCAF8 NUP98 NUP42 NUP58 RFX7 POM121C PIAS1 MCM3AP RPRD2 NUP153 | 9.53e-10 | 180 | 162 | 11 | 35198878 |
| Pubmed | ZEB1 TCF12 INTS12 ASH1L GATA2 KDM3B NUP42 MLLT10 PHF8 SRCAP TRIM24 PIAS1 TFCP2 ZFP36 PER3 EGR1 TRIM28 SLTM ELF3 TBX20 | 1.42e-09 | 808 | 162 | 20 | 20412781 | |
| Pubmed | 1.53e-09 | 25 | 162 | 6 | 10601273 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EVL RBM15 ZEB1 SCAF8 NUP98 KDM3B NUP214 PHF8 RREB1 RFX7 MAPK8IP3 SCAF1 LATS1 TRIM28 CCNL1 IRS2 TACC3 MAP4K4 NUP153 | 4.30e-09 | 774 | 162 | 19 | 15302935 |
| Pubmed | Integrated structural analysis of the human nuclear pore complex scaffold. | 5.04e-09 | 30 | 162 | 6 | 24315095 | |
| Pubmed | 5.04e-09 | 30 | 162 | 6 | 27016207 | ||
| Pubmed | 5.96e-09 | 15 | 162 | 5 | 14697343 | ||
| Pubmed | EGLN2 UBQLN2 UBQLN1 SIPA1L3 UBQLN4 ASH1L NCKAP5 SRGAP2 NUP42 NUP58 DCTN1 PIAS1 ZFP36 MAPK8IP3 TRIM66 SETDB1 SEC23IP NAV3 MACF1 KIF5A OLIG2 MAP4K4 AFF4 AGAP1 | 7.41e-09 | 1285 | 162 | 24 | 35914814 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NUP98 KDM3B SRGAP2 NUP214 SRCAP POM121C DCTN1 TFCP2 MAVS TRIM28 CLMN SEC23IP MACF1 RPRD2 BOD1L1 IRS2 HCFC1 NUP153 AFF4 PRRC2B | 1.61e-08 | 934 | 162 | 20 | 33916271 |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.68e-08 | 18 | 162 | 5 | 18834073 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | TCF3 TCF12 ASH1L GATA2 MLLT10 TRIM24 TFCP2 ZFP36 SP8 PER2 EGR1 TRIM28 ZNF408 VAX2 DLX2 TBX20 HCFC1 DNMT3L PROX1 | 3.15e-08 | 877 | 162 | 19 | 20211142 |
| Pubmed | 3.28e-08 | 104 | 162 | 8 | 10470851 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | SCAF8 NUP98 NUP214 NUP42 NUP58 POM121C TRIM24 ZNF503 NUP54 POM121 MCM3AP SEC23IP NUP153 PRRC2B | 3.54e-08 | 457 | 162 | 14 | 32344865 |
| Pubmed | ZNF536 TCF12 ATXN7L1 ASH1L PHF8 RREB1 SRCAP POM121C TRIM24 TRIM66 SCAF1 SETDB1 TRIM28 MCM3AP MACF1 VAX2 ELF3 IRS2 AFF4 PRRC2B PROX1 | 6.21e-08 | 1116 | 162 | 21 | 31753913 | |
| Pubmed | ZNF536 ZEB1 UBQLN4 MSANTD2 NUP214 RREB1 TRIM24 DCTN1 SETDB1 SEC23IP IRS2 TACC3 PROX1 | 9.33e-08 | 418 | 162 | 13 | 34709266 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 23053434 | ||
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 9.92e-08 | 3 | 162 | 3 | 30802453 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 35507432 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 9847314 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 27483328 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 24939955 | ||
| Pubmed | Expression of mucin (MUC) genes in mucoepidermoid carcinoma. | 9.92e-08 | 3 | 162 | 3 | 21072847 | |
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 9.92e-08 | 3 | 162 | 3 | 17592322 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 17098253 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 35879412 | ||
| Pubmed | The nuclear pore complex: a new dynamic in HIV-1 replication. | 9.92e-08 | 3 | 162 | 3 | 21327100 | |
| Pubmed | RBM15 ATXN7L1 PHF8 TRIM24 PIAS1 RPRD2 POLQ SPTY2D1 HCFC1 AFF4 | 1.02e-07 | 222 | 162 | 10 | 37071664 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KRT5 RBM15 INTS12 TBC1D2B ARHGAP17 NUP42 NUP58 ZCCHC2 SRCAP PIAS1 SETDB1 MCM3AP MACF1 BSN PRRC2B | 1.23e-07 | 588 | 162 | 15 | 38580884 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TBX22 TCF3 ZEB1 TCF12 ASH1L GATA2 LHX3 RREB1 RFX7 ZHX2 TFCP2 EGR1 VAX2 ELF3 DLX2 TBX20 OLIG2 PROX1 | 2.75e-07 | 908 | 162 | 18 | 19274049 |
| Pubmed | 3.14e-07 | 13 | 162 | 4 | 21318276 | ||
| Pubmed | ZNF536 SCAF8 KDM3B ARHGAP17 SRGAP2 NUP214 RREB1 ZNF503 SETDB1 MAVS CLMN SEC23IP RPRD2 BOD1L1 MAP4K4 HCFC1 | 3.73e-07 | 733 | 162 | 16 | 34672954 | |
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 3.95e-07 | 4 | 162 | 3 | 17900573 | |
| Pubmed | Herp enhances ER-associated protein degradation by recruiting ubiquilins. | 3.95e-07 | 4 | 162 | 3 | 18307982 | |
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 3.95e-07 | 4 | 162 | 3 | 39024979 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RBM15 TCF3 INTS12 UBQLN4 GATA2 NUP98 NUP214 PHF8 RREB1 SRCAP RFX7 POM121C TFCP2 SCAF1 TRIM28 SLTM RPRD2 SPTY2D1 HCFC1 NUP153 SAMD4A | 7.05e-07 | 1294 | 162 | 21 | 30804502 |
| Pubmed | Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. | 9.85e-07 | 5 | 162 | 3 | 11827521 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | TCF12 YY2 KDM3B NUP214 TRIM24 PIAS1 TRIM28 RPRD2 HCFC1 NUP153 PRRC2B | 1.03e-06 | 357 | 162 | 11 | 37059091 |
| Pubmed | 1.03e-06 | 17 | 162 | 4 | 26187199 | ||
| Pubmed | 1.19e-06 | 40 | 162 | 5 | 37516964 | ||
| Pubmed | SIPA1L3 NUP98 NUP214 NUP42 CD320 POM121C TFCP2 NUP54 LATS1 POM121 MAVS MCM3AP SEC23IP GCC1 MAP3K21 CDC25C SPTY2D1 PRRC2B | 1.21e-06 | 1007 | 162 | 18 | 34597346 | |
| Pubmed | 1.69e-06 | 121 | 162 | 7 | 22412018 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | TCF12 YY2 GATA2 RFX7 TFCP2 SP8 EGR1 VAX2 ELF3 DLX2 TBX20 OLIG2 PROX1 | 1.81e-06 | 544 | 162 | 13 | 28473536 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | EVL TCF3 TCF12 NCKIPSD TBC1D2B KDM3B ZNRF2 TFCP2 ZFP36 MAP3K1 SETDB1 MCM3AP SEC23IP RPRD2 IRS2 MAP4K4 AGAP1 SAMD4A | 1.86e-06 | 1038 | 162 | 18 | 26673895 |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 35247097 | ||
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 23439647 | ||
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 11266456 | ||
| Pubmed | KDM3B PHF8 SRCAP DCTN1 LATS1 TRIM28 SEC23IP RPRD2 BOD1L1 TACC3 MAP4K4 HCFC1 PRRC2B | 2.00e-06 | 549 | 162 | 13 | 38280479 | |
| Pubmed | Human immunodeficiency virus type 1 Vpr: functions and molecular interactions. | 2.07e-06 | 20 | 162 | 4 | 19458171 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 2.10e-06 | 125 | 162 | 7 | 32891193 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.60e-06 | 184 | 162 | 8 | 32908313 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 20059542 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 11238447 | ||
| Pubmed | ID1 and CEBPA coordinate epidermal progenitor cell differentiation. | 3.42e-06 | 7 | 162 | 3 | 36330928 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 30664872 | ||
| Pubmed | Crosstalk between Lys63- and Lys11-polyubiquitin signaling at DNA damage sites is driven by Cezanne. | 3.69e-06 | 50 | 162 | 5 | 31699778 | |
| Pubmed | EVL KRT5 INTS12 TRO SIPA1L3 ASH1L NUP98 GRIA1 SRCAP MINDY2 DCTN1 NUP54 LATS1 SEC23IP NAV2 MACF1 BOD1L1 KIF5A BSN POLQ PRRC2B | 3.87e-06 | 1442 | 162 | 21 | 35575683 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | RBM15 TCF12 NUP98 COP1 NUP58 PIAS1 NUP54 TRIM28 SLTM SPTY2D1 HCFC1 | 3.98e-06 | 411 | 162 | 11 | 35182466 |
| Pubmed | ROR1 NUP42 POM121C POM121 SEC23IP MACF1 MAP4K4 NUP153 PRRC2B | 4.35e-06 | 263 | 162 | 9 | 34702444 | |
| Pubmed | Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery. | 5.46e-06 | 8 | 162 | 3 | 23459205 | |
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 27582690 | ||
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 5.46e-06 | 8 | 162 | 3 | 31375530 | |
| Pubmed | UBQLN2 UBQLN1 TRO UBQLN4 ZHX2 TFCP2 SCAF1 SETDB1 POM121 GCC1 SYVN1 PRRC2B RAD23A | 6.05e-06 | 608 | 162 | 13 | 16713569 | |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 6.50e-06 | 56 | 162 | 5 | 9455484 | |
| Pubmed | 8.16e-06 | 9 | 162 | 3 | 9114010 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | TCF12 KDM3B ZHX2 TRIM24 PIAS1 TFCP2 MAVS TRIM28 SLTM MED26 HCFC1 | 8.25e-06 | 444 | 162 | 11 | 34795231 |
| Pubmed | 8.51e-06 | 28 | 162 | 4 | 20012529 | ||
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 19581287 | ||
| Pubmed | EVL RBM15 TCF3 TCF12 UBQLN1 INTS12 KDM3B MSANTD2 RREB1 TRIM24 PIAS1 ZNF503 EGR1 HCFC1 NUP153 PRRC2B RAD23A | 1.69e-05 | 1103 | 162 | 17 | 34189442 | |
| Pubmed | KRT5 TCF12 STON1 AFF2 NUP98 KDM3B MUC16 MAVS SEC23IP GCC1 TACC3 SPTY2D1 PRRC2B AGAP1 | 1.81e-05 | 777 | 162 | 14 | 35844135 | |
| Pubmed | Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. | 1.89e-05 | 34 | 162 | 4 | 18539113 | |
| Pubmed | LMO4 controls the balance between excitatory and inhibitory spinal V2 interneurons. | 2.12e-05 | 12 | 162 | 3 | 19323994 | |
| Pubmed | Molecular basis of pituitary dysfunction in mouse and human. | 2.12e-05 | 12 | 162 | 3 | 11420609 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EVL CACNB2 TCF3 STXBP5L ATXN7L1 SCAF8 FAM53A SIPA1L3 ASH1L SRGAP2 ZHX2 MAPK8IP3 CLMN MACF1 RPRD2 BOD1L1 MBD5 AFF4 AGAP1 PDZD2 | 2.16e-05 | 1489 | 162 | 20 | 28611215 |
| Pubmed | Downregulation of E Protein Activity Augments an ILC2 Differentiation Program in the Thymus. | 2.16e-05 | 2 | 162 | 2 | 28258196 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 17222321 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 18093538 | ||
| Pubmed | Roles of Insulin Receptor Substrates (IRS) in renal function and renal hemodynamics. | 2.16e-05 | 2 | 162 | 2 | 33270683 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 16194893 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 28885228 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15975995 | ||
| Pubmed | Systematic modeling for the insulin signaling network mediated by IRS(1) and IRS(2). | 2.16e-05 | 2 | 162 | 2 | 24703981 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 10958665 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 26709696 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 20154672 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 27708333 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22271902 | ||
| Pubmed | De novo DNA methylation of endogenous retroviruses is shaped by KRAB-ZFPs/KAP1 and ESET. | 2.16e-05 | 2 | 162 | 2 | 23293284 | |
| Pubmed | E2A promotes the survival of precursor and mature B lymphocytes. | 2.16e-05 | 2 | 162 | 2 | 16888011 | |
| Interaction | APC interactions | KRT5 NUP98 NCKAP5 NUP214 NUP42 NUP58 POM121C DCTN1 NUP54 SETDB1 LATS1 POM121 ZNF408 MCM3AP NAV3 NAV2 MACF1 MBD5 MUC1 NUP153 | 3.07e-11 | 389 | 158 | 20 | int:APC |
| Interaction | YWHAH interactions | RBM15 INTS12 SPEG SIPA1L3 NCKIPSD KDM3B ARHGAP17 IRS1 SRGAP2 PLEKHG2 RFX7 DCTN1 ZNRF2 ZFP36 CCNF LATS1 CLMN NAV2 MACF1 BOD1L1 IRS2 KIF5A MAP3K21 CDC25C MAP4K4 MEX3B AGAP1 SAMD4A | 3.23e-08 | 1102 | 158 | 28 | int:YWHAH |
| Interaction | NUP35 interactions | SCAF8 NUP98 NUP214 NUP42 NUP58 POM121C TRIM24 ZNF503 NUP54 POM121 MAVS TRIM28 MCM3AP SEC23IP NUP153 PRRC2B PDZD2 | 4.10e-08 | 424 | 158 | 17 | int:NUP35 |
| Interaction | TOP3B interactions | RBM15 SPEG SIPA1L3 GATA2 KDM3B ARHGAP17 IRS1 SRGAP2 NUP214 CACFD1 MLLT10 SRCAP POM121C DCTN1 TFCP2 ZFP36 MAPK8IP3 ZNF503 CCNF SCAF1 PER2 TRIM28 ZNF408 MCM3AP NAV2 DLX2 IRS2 SYVN1 MBD5 HCFC1 MEX3B PRRC2B | 1.07e-07 | 1470 | 158 | 32 | int:TOP3B |
| Interaction | MAPRE1 interactions | NUP98 ARHGAP17 NUP214 NUP42 NUP58 DNAJC6 DCTN1 NUP54 CCNF MAVS NAV3 NAV2 MACF1 TACC3 MED26 POM121B NUP153 PRRC2B | 1.23e-07 | 514 | 158 | 18 | int:MAPRE1 |
| Interaction | DTX2 interactions | TCF3 SCAF8 DOK3 UBQLN4 NUP98 NUP42 NUP58 RFX7 POM121C PIAS1 ZNF503 MCM3AP RPRD2 NUP153 | 3.48e-07 | 330 | 158 | 14 | int:DTX2 |
| Interaction | YWHAG interactions | RBM15 SPEG SIPA1L3 NCKIPSD KDM3B ARHGAP17 IRS1 SRGAP2 PLEKHG2 RFX7 ZNRF2 PIAS1 ZFP36 MAP3K1 CCNF LATS1 CLMN NAV2 MACF1 BOD1L1 IRS2 KIF5A MAP3K21 CDC25C MAP4K4 MEX3B AGAP1 SAMD4A | 4.22e-07 | 1248 | 158 | 28 | int:YWHAG |
| Interaction | NUP43 interactions | RBM15 ASH1L NUP98 MUC19 NUP214 NUP42 PHF8 SRCAP ZHX2 POM121C NUP54 SCAF1 POM121 MAVS MCM3AP BOD1L1 HCFC1 NUP153 PDZD2 | 4.74e-07 | 625 | 158 | 19 | int:NUP43 |
| Interaction | SLX4 interactions | RBM15 TCF12 ATXN7L1 YY2 KDM3B COP1 NUP214 PHF8 TRIM24 PIAS1 TRIM28 RPRD2 POLQ SPTY2D1 HCFC1 NUP153 AFF4 PRRC2B | 5.91e-07 | 572 | 158 | 18 | int:SLX4 |
| Interaction | CREBBP interactions | TCF3 ZEB1 TCF12 GATA2 NUP98 KDM3B LHX3 SRCAP TRIM24 PIAS1 SETDB1 LATS1 EGR1 TRIM28 ELF3 KIF5A PROX1 RAD23A | 1.15e-06 | 599 | 158 | 18 | int:CREBBP |
| Interaction | GLE1 interactions | 2.88e-06 | 150 | 158 | 9 | int:GLE1 | |
| Interaction | YWHAZ interactions | EVL ASXL1 RBM15 SPEG SIPA1L3 NCKIPSD COP1 IRS1 SRGAP2 ZHX2 DCTN1 PIAS1 MAP3K1 CCNF LATS1 PER2 CAMKV NAV2 MACF1 IRS2 KIF5A MAP3K21 CDC25C TNS1 MEX3B AGAP1 SAMD4A | 4.00e-06 | 1319 | 158 | 27 | int:YWHAZ |
| Interaction | NUP155 interactions | ROR1 NUP98 NUP214 NUP42 NUP58 POM121C NUP54 CCNF POM121 MAVS CLMN MCM3AP SEC23IP SYVN1 NUP153 | 5.48e-06 | 477 | 158 | 15 | int:NUP155 |
| Interaction | HELZ interactions | CHIA PPP4R1L NUP42 ZCCHC2 POM121C TRIM24 ZFP36 CCNF POM121 MEX3B PRRC2B | 6.04e-06 | 257 | 158 | 11 | int:HELZ |
| Interaction | YWHAQ interactions | TCF3 SPEG SIPA1L3 UBQLN4 NCKIPSD IRS1 SRGAP2 RFX7 ZHX2 ZNRF2 TFCP2 ZFP36 MAP3K1 CCNF LATS1 TRIM28 NAV2 MACF1 IRS2 KIF5A MAP3K21 CDC25C AGAP1 SAMD4A | 6.71e-06 | 1118 | 158 | 24 | int:YWHAQ |
| Interaction | NUP58 interactions | 7.99e-06 | 92 | 158 | 7 | int:NUP58 | |
| Interaction | TLE3 interactions | TCF3 TCF12 SCAF8 GATA2 MLLT10 PIAS1 ZNF503 NUP54 CCNF POM121 EGR1 MCM3AP TBX20 | 8.72e-06 | 376 | 158 | 13 | int:TLE3 |
| Interaction | SERPINI2 interactions | 1.02e-05 | 18 | 158 | 4 | int:SERPINI2 | |
| Interaction | NUP62 interactions | ASXL1 NUP98 NUP214 NUP58 TRIM24 NUP54 TRIM28 KIF5A TACC3 MUC1 NUP153 | 1.07e-05 | 273 | 158 | 11 | int:NUP62 |
| Interaction | GIGYF1 interactions | 1.11e-05 | 177 | 158 | 9 | int:GIGYF1 | |
| Interaction | DPPA3 interactions | 1.42e-05 | 67 | 158 | 6 | int:DPPA3 | |
| Interaction | NUP188 interactions | 2.23e-05 | 148 | 158 | 8 | int:NUP188 | |
| Interaction | NUP214 interactions | 2.40e-05 | 195 | 158 | 9 | int:NUP214 | |
| Interaction | SFN interactions | TCF3 SIPA1L3 COP1 IRS1 SRGAP2 PIAS1 ZFP36 LATS1 TRIM28 CLMN NAV2 MACF1 IRS2 MAP3K21 CDC25C MAP4K4 SAMD4A | 3.19e-05 | 692 | 158 | 17 | int:SFN |
| Interaction | PAX6 interactions | ZNF536 ZEB1 MSANTD2 RREB1 SRCAP ZHX2 TRIM24 ZNF503 VAX2 PRRC2B DNMT3L PROX1 | 3.29e-05 | 366 | 158 | 12 | int:PAX6 |
| Interaction | FEV interactions | 3.29e-05 | 203 | 158 | 9 | int:FEV | |
| Interaction | HAND1 interactions | 3.42e-05 | 24 | 158 | 4 | int:HAND1 | |
| Interaction | KLC1 interactions | ARHGAP17 MINDY2 PIAS1 MAPK8IP3 ZNF503 CCNF TRIM28 SEC23IP KIF5A TACC3 | 3.42e-05 | 255 | 158 | 10 | int:KLC1 |
| Interaction | YWHAB interactions | SPEG SIPA1L3 NCKIPSD COP1 IRS1 SRGAP2 RFX7 DCTN1 TFCP2 ZFP36 CCNF LATS1 NAV2 MACF1 IRS2 KIF5A MAP3K21 CDC25C MEX3B AGAP1 SAMD4A | 4.52e-05 | 1014 | 158 | 21 | int:YWHAB |
| Interaction | GARRE1 interactions | 5.28e-05 | 167 | 158 | 8 | int:GARRE1 | |
| Interaction | UBE2I interactions | TCF3 UBQLN2 UBQLN1 UBQLN4 NUP98 NUP214 TRIM24 PIAS1 TFCP2 MAP3K1 CCNF SETDB1 LATS1 TRIM28 ZNF408 NUP153 | 5.79e-05 | 654 | 158 | 16 | int:UBE2I |
| Interaction | EPS15 interactions | 6.15e-05 | 220 | 158 | 9 | int:EPS15 | |
| Interaction | MYO6 interactions | EVL SIPA1L3 DCTN1 TFCP2 CCNF TRIM28 ELF3 RPRD2 SYVN1 MAP4K4 HCFC1 RAD23A | 7.37e-05 | 398 | 158 | 12 | int:MYO6 |
| Interaction | PSORS1C2 interactions | 7.41e-05 | 29 | 158 | 4 | int:PSORS1C2 | |
| Interaction | SEZ6L interactions | 7.45e-05 | 11 | 158 | 3 | int:SEZ6L | |
| Interaction | PLAAT3 interactions | 7.45e-05 | 11 | 158 | 3 | int:PLAAT3 | |
| Interaction | MDK interactions | 8.13e-05 | 91 | 158 | 6 | int:MDK | |
| Interaction | NAA40 interactions | NUP98 KDM3B SRGAP2 NUP214 SRCAP POM121C DCTN1 TFCP2 MAVS TRIM28 CLMN SEC23IP MACF1 RPRD2 BOD1L1 IRS2 HCFC1 NUP153 AFF4 PRRC2B | 8.28e-05 | 978 | 158 | 20 | int:NAA40 |
| Interaction | NUMA1 interactions | UBQLN4 NUP98 NUP214 NUP42 NUP58 SRCAP NUP54 CCNF SETDB1 TRIM28 MACF1 MAP4K4 NUP153 | 8.62e-05 | 469 | 158 | 13 | int:NUMA1 |
| Interaction | JUN interactions | NCKIPSD GATA2 COP1 CACFD1 PIAS1 MAP3K1 PER2 EGR1 MACF1 ELF3 MUC1 HCFC1 DNMT3L | 8.80e-05 | 470 | 158 | 13 | int:JUN |
| Interaction | CNOT9 interactions | 8.94e-05 | 231 | 158 | 9 | int:CNOT9 | |
| Interaction | ZG16 interactions | 9.88e-05 | 12 | 158 | 3 | int:ZG16 | |
| Interaction | MAPK9 interactions | 1.12e-04 | 186 | 158 | 8 | int:MAPK9 | |
| Interaction | YWHAE interactions | RBM15 SIPA1L3 DOK3 NCKIPSD IRS1 SRGAP2 DCTN1 MAP3K1 CCNF LATS1 PER2 TRIM28 SEC23IP NAV2 MACF1 IRS2 KIF5A MAP3K21 CDC25C MEX3B AGAP1 SAMD4A RAD23A | 1.25e-04 | 1256 | 158 | 23 | int:YWHAE |
| Interaction | PLAAT2 interactions | 1.28e-04 | 13 | 158 | 3 | int:PLAAT2 | |
| Interaction | CNOT4 interactions | 1.57e-04 | 65 | 158 | 5 | int:CNOT4 | |
| Interaction | NXF2 interactions | 1.57e-04 | 65 | 158 | 5 | int:NXF2 | |
| Interaction | TACC3 interactions | 1.69e-04 | 148 | 158 | 7 | int:TACC3 | |
| Interaction | GATA2 interactions | 1.79e-04 | 199 | 158 | 8 | int:GATA2 | |
| Interaction | SLC5A10 interactions | 1.82e-04 | 3 | 158 | 2 | int:SLC5A10 | |
| Interaction | SMIM2 interactions | 1.82e-04 | 3 | 158 | 2 | int:SMIM2 | |
| Interaction | DEFB115 interactions | 1.82e-04 | 3 | 158 | 2 | int:DEFB115 | |
| Interaction | JPH4 interactions | 1.95e-04 | 68 | 158 | 5 | int:JPH4 | |
| Interaction | NUP62CL interactions | 1.96e-04 | 37 | 158 | 4 | int:NUP62CL | |
| Interaction | PHF13 interactions | 2.01e-04 | 15 | 158 | 3 | int:PHF13 | |
| Interaction | MSC interactions | 2.01e-04 | 15 | 158 | 3 | int:MSC | |
| Interaction | PIN1 interactions | TCF12 UBQLN2 UBQLN4 NCKIPSD NUP98 PLEKHG2 CCNF EGR1 TRIM28 KIF5A CDC25C | 2.25e-04 | 383 | 158 | 11 | int:PIN1 |
| Interaction | BRCA2 interactions | ASXL1 SMARCAL1 PPP4R1L NCKAP5 SRCAP PIAS1 ZNF503 TRIM28 RPRD2 POLQ RAD23A | 2.30e-04 | 384 | 158 | 11 | int:BRCA2 |
| Interaction | NR3C1 interactions | ZNF536 SMARCAL1 YY2 NUP98 KDM3B MUC16 NUP214 POM121C TRIM24 PIAS1 NUP54 EGR1 TRIM28 SEC23IP IRS2 BSN NUP153 PRRC2B DNMT3L | 2.31e-04 | 974 | 158 | 19 | int:NR3C1 |
| Interaction | YY1 interactions | ASXL1 TCF3 INTS12 YY2 MSANTD2 LHX3 SRCAP ZHX2 TRIM24 TFCP2 HCFC1 DNMT3L | 2.51e-04 | 454 | 158 | 12 | int:YY1 |
| Interaction | KRT6A interactions | 2.73e-04 | 160 | 158 | 7 | int:KRT6A | |
| Interaction | USP54 interactions | 2.74e-04 | 212 | 158 | 8 | int:USP54 | |
| Interaction | NUP93 interactions | 2.80e-04 | 269 | 158 | 9 | int:NUP93 | |
| Interaction | SEM1 interactions | 2.94e-04 | 162 | 158 | 7 | int:SEM1 | |
| Interaction | FIGLA interactions | 2.97e-04 | 17 | 158 | 3 | int:FIGLA | |
| Interaction | NUP153 interactions | 3.11e-04 | 216 | 158 | 8 | int:NUP153 | |
| Interaction | FHL3 interactions | 3.38e-04 | 276 | 158 | 9 | int:FHL3 | |
| Interaction | CTIF interactions | 3.49e-04 | 77 | 158 | 5 | int:CTIF | |
| Interaction | NUP107 interactions | 3.63e-04 | 221 | 158 | 8 | int:NUP107 | |
| Interaction | XRCC6 interactions | ASXL1 ZEB1 UBQLN2 INTS12 TRIM24 PIAS1 TFCP2 CCNF TRIM28 ELF3 RPRD2 BOD1L1 DLX2 MBD5 TBX20 HCFC1 NUP153 AFF4 | 3.64e-04 | 928 | 158 | 18 | int:XRCC6 |
| Interaction | KPNB1 interactions | ASXL1 UBQLN2 NUP98 NUP214 NUP42 POM121C NUP54 CCNF POM121 PER2 SYVN1 CDC25C NUP153 | 3.67e-04 | 544 | 158 | 13 | int:KPNB1 |
| Interaction | ELK3 interactions | 3.70e-04 | 120 | 158 | 6 | int:ELK3 | |
| Interaction | CAMSAP2 interactions | 3.80e-04 | 169 | 158 | 7 | int:CAMSAP2 | |
| Interaction | PML interactions | TCF12 GATA2 KDM3B COP1 ZHX2 TRIM24 PIAS1 TFCP2 EZHIP CCNF TRIM66 SETDB1 PER2 MAVS TRIM28 SLTM MED26 HCFC1 | 3.88e-04 | 933 | 158 | 18 | int:PML |
| Interaction | ASCL1 interactions | 4.22e-04 | 45 | 158 | 4 | int:ASCL1 | |
| Interaction | HDAC1 interactions | ZNF536 ZEB1 UBQLN4 NUP98 NUP214 RREB1 ZHX2 DNAJC6 DCTN1 TFCP2 ZFP36 NUP54 CCNF SETDB1 TRIM28 SEC23IP IRS2 TACC3 HCFC1 DNMT3L | 4.29e-04 | 1108 | 158 | 20 | int:HDAC1 |
| Interaction | KDM1A interactions | TCF3 ZEB1 UBQLN4 GATA2 MSANTD2 NUP214 PHF8 RREB1 TRIM24 DNAJC6 DCTN1 SETDB1 TRIM28 SEC23IP GCC1 IRS2 TACC3 PROX1 | 4.29e-04 | 941 | 158 | 18 | int:KDM1A |
| Interaction | SIPA1L1 interactions | 4.53e-04 | 174 | 158 | 7 | int:SIPA1L1 | |
| Interaction | SRGN interactions | 4.89e-04 | 20 | 158 | 3 | int:SRGN | |
| Interaction | HERPUD1 interactions | 4.99e-04 | 47 | 158 | 4 | int:HERPUD1 | |
| Interaction | MINDY3 interactions | 4.99e-04 | 47 | 158 | 4 | int:MINDY3 | |
| Cytoband | 2p12 | 3.98e-06 | 117 | 162 | 6 | 2p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | 1.16e-04 | 213 | 162 | 6 | chr2p11 | |
| Cytoband | 10p12 | 2.57e-04 | 7 | 162 | 2 | 10p12 | |
| Cytoband | 1q21 | 3.14e-04 | 91 | 162 | 4 | 1q21 | |
| Cytoband | 1p32-p31 | 4.38e-04 | 9 | 162 | 2 | 1p32-p31 | |
| Cytoband | Xp11.22 | 9.37e-04 | 54 | 162 | 3 | Xp11.22 | |
| GeneFamily | Nucleoporins | 5.93e-08 | 32 | 120 | 6 | 1051 | |
| GeneFamily | CD molecules|Mucins | 2.21e-07 | 21 | 120 | 5 | 648 | |
| GeneFamily | PHD finger proteins | 2.25e-06 | 90 | 120 | 7 | 88 | |
| GeneFamily | Ubiquilin family | 2.82e-06 | 5 | 120 | 3 | 783 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | 1.88e-05 | 83 | 120 | 6 | 351 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 2.60e-04 | 4 | 120 | 2 | 1145 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.19e-03 | 8 | 120 | 2 | 837 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.53e-03 | 9 | 120 | 2 | 1280 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 2.31e-03 | 11 | 120 | 2 | 1025 | |
| GeneFamily | Ring finger proteins | 2.41e-03 | 275 | 120 | 7 | 58 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.34e-03 | 15 | 120 | 2 | 529 | |
| GeneFamily | T-boxes | 6.24e-03 | 18 | 120 | 2 | 766 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | RBM15 TCF3 TCF12 NCKIPSD NUP98 NUP214 MLLT10 TRIM24 MUC1 OLIG2 AFF4 | 4.80e-06 | 323 | 159 | 11 | M9150 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ASXL1 ZEB1 TCF12 SCAF8 ROR1 NUP98 KDM3B IRS1 SRGAP2 PHF8 ZHX2 TRIM24 SETDB1 NAV3 MACF1 NUP153 AGAP1 SAMD4A | 4.84e-06 | 856 | 159 | 18 | M4500 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP | 1.16e-05 | 174 | 159 | 8 | M40888 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE | SIPA1L3 PPP4R1L ZCCHC2 RREB1 ZFP36 POM121 EGR1 IRS2 MED26 SPTY2D1 MEX3B | 1.63e-05 | 368 | 159 | 11 | M41100 |
| Coexpression | GSE29618_BCELL_VS_MDC_UP | 2.55e-05 | 194 | 159 | 8 | M4943 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN | 2.74e-05 | 196 | 159 | 8 | M4973 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP | 3.05e-05 | 199 | 159 | 8 | M8961 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 4.64e-05 | 155 | 159 | 7 | M39246 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 5.04e-05 | 157 | 159 | 7 | M7733 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 5.25e-05 | 158 | 159 | 7 | M372 | |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 7.17e-05 | 166 | 159 | 7 | M7722 | |
| Coexpression | NAGASHIMA_NRG1_SIGNALING_UP | 8.96e-05 | 172 | 159 | 7 | M11585 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | TBX22 TCF3 UBQLN1 AFF2 STXBP5L TRO GATA2 PLEKHG2 TRIM24 ZFP36 ZFYVE28 EGR1 MCM3AP DACT3 SLTM MACF1 VAX2 BOD1L1 DLX2 TACC3 MUC4 | 1.20e-05 | 989 | 156 | 21 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ASXL1 NUP98 ZFP36 PER2 EGR1 CCNL1 TMEM108 NUP153 AFF4 SAMD4A | 2.33e-09 | 192 | 162 | 10 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TCF3 TCF12 DOK3 ARHGAP17 IRS1 MAP3K1 NAV2 TMEM108 IRS2 SYVN1 | 2.58e-09 | 194 | 162 | 10 | 11709704079f24a730476572dc2f01e9d2226e2c |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TCF3 TCF12 DOK3 ARHGAP17 IRS1 MAP3K1 NAV2 TMEM108 IRS2 SYVN1 | 2.58e-09 | 194 | 162 | 10 | 3a1f95639d5f239f001bd67d4213e8938e7f299d |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CD320 IGLV3-19 IGKV3D-20 FCRL5 SYVN1 IGKV4-1 IGKV3-20 IGKV3-7 PARM1 | 2.15e-08 | 180 | 162 | 9 | 6a777a308fa3160d31eda468db930e71862020b2 |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-08 | 185 | 162 | 9 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-08 | 191 | 162 | 9 | 318323a12029a7992f16382cb0c186f5b2e1ca47 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-08 | 191 | 162 | 9 | 4aa29337f4d2528577bb90dc4abfb6eab93e120f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.92e-08 | 193 | 162 | 9 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 4.47e-08 | 196 | 162 | 9 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, condition lineage and cell class | 5.09e-08 | 199 | 162 | 9 | 1b17e6d5e6b994dec65efae2667f4f1f438161b1 | |
| ToppCell | Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, Lineage and Cell Type | 1.21e-07 | 158 | 162 | 8 | 05a29c2d5506a25ccdfa4c6a86e9188977a18272 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.94e-07 | 168 | 162 | 8 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | TCF3 IGKV3D-20 FCRL5 IGKV6-21 IGKV4-1 IGKV3-20 IGKV3-7 PARM1 | 4.21e-07 | 186 | 162 | 8 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 4.21e-07 | 186 | 162 | 8 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.35e-07 | 192 | 162 | 8 | ca4d8e540d9e6fa47ecf97648cbd5abfc7ab7f85 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-07 | 192 | 162 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 5'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.02e-07 | 195 | 162 | 8 | 600174e35574fe7c44dd923adcf43686e7b01e39 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.26e-07 | 196 | 162 | 8 | c2d17630f7bfc9e727de55e093c17fddac61b61f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.26e-07 | 196 | 162 | 8 | 54c30023d04e7265373647f56fc93885804938b0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-06 | 162 | 162 | 7 | 8278dccdb139396ede34b83b02ebce837f2489d6 | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-06 | 166 | 162 | 7 | 4ba3711a02d3695b27f7cefd7c60e3be009f5bef | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-06 | 166 | 162 | 7 | 35f6ae2664935dda0d883b32a050ced843204f2d | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-06 | 167 | 162 | 7 | f2185eb72f0137136f6d71af2a70168fded6c940 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-06 | 167 | 162 | 7 | 5e768cf24699893e05d1bcb1c92dba2336943a64 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 2.91e-06 | 169 | 162 | 7 | a65853ff9f6489cc1617cbba0d03b392d23c1528 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.27e-06 | 172 | 162 | 7 | b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63 | |
| ToppCell | Control-Lymphoid-B_Plasma|Control / Disease state, Lineage and Cell class | 3.27e-06 | 172 | 162 | 7 | 61e33836b8cb0f347f3e699eb587a37073b6fa4c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-06 | 173 | 162 | 7 | 0ca2169a275404118038c0489a48062879488765 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-06 | 173 | 162 | 7 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.10e-06 | 178 | 162 | 7 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | COVID-19-lung-Plasmablasts|lung / Disease (COVID-19 only), tissue and cell type | 5.47e-06 | 186 | 162 | 7 | 81caf67da9fed09c77b7ddcab9b0b8e4fab2de97 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.67e-06 | 187 | 162 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-06 | 188 | 162 | 7 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 5.87e-06 | 188 | 162 | 7 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | Severe_COVID-19-B_cell|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.08e-06 | 189 | 162 | 7 | 59ce8f15f413557d2059ee6b53ba5957b864cb8e | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.08e-06 | 189 | 162 | 7 | b0fcbe13a91a4b8dfa507b7a484f45477ef31609 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.08e-06 | 189 | 162 | 7 | d5d25f4151ea96e2d4b3a0e0910e7ff995eaf752 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-06 | 189 | 162 | 7 | a1bda6ed5c52a5d33d229018cb5982cae6305533 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Late_pre-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.08e-06 | 189 | 162 | 7 | 3012e67093ca7c281ee8f1b68064646961f250f9 | |
| ToppCell | Severe_COVID-19-B_cell-Plasmablast|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.08e-06 | 189 | 162 | 7 | d7bfefc8c35374c5288807349a76dbb10e84c52b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.08e-06 | 189 | 162 | 7 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | COVID-19-lung-Plasmablasts|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.08e-06 | 189 | 162 | 7 | fdf6c945b352614885e646a5ef4bc576dee73895 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.08e-06 | 189 | 162 | 7 | 0f0607642eecc66222d23afe6d77b6872343cb8e | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.29e-06 | 190 | 162 | 7 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 | |
| ToppCell | BAL-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.29e-06 | 190 | 162 | 7 | d55b9f9b82bd2b2e1ea2446813fce04f04a1dcdf | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.29e-06 | 190 | 162 | 7 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 | |
| ToppCell | severe-Lymphocytic-Plasmablast|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.51e-06 | 191 | 162 | 7 | 73660d762c9d451980c21adc426db6670bcaf37f | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 6.51e-06 | 191 | 162 | 7 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-06 | 191 | 162 | 7 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-06 | 191 | 162 | 7 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 192 | 162 | 7 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.74e-06 | 192 | 162 | 7 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 6.74e-06 | 192 | 162 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 192 | 162 | 7 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.97e-06 | 193 | 162 | 7 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.97e-06 | 193 | 162 | 7 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.21e-06 | 194 | 162 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-06 | 194 | 162 | 7 | ad1aacff97beb76f4211942676e1d5e84087d44e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.21e-06 | 194 | 162 | 7 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.21e-06 | 194 | 162 | 7 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-06 | 194 | 162 | 7 | fdd59b1e036b2d6d8877e1a920a0e56a91a2a882 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.46e-06 | 195 | 162 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.71e-06 | 196 | 162 | 7 | c38e7f533c619afe008de0e99042f7180c2da918 | |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 7.71e-06 | 196 | 162 | 7 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.97e-06 | 197 | 162 | 7 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.24e-06 | 198 | 162 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.24e-06 | 198 | 162 | 7 | 076c862f2a723f0361749377561cae902068b1a0 | |
| ToppCell | 5'-Adult|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.51e-06 | 199 | 162 | 7 | 8b7b1fcea9a06522fdfab85d0dfd33010ae96d75 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-Plasmablast|COVID-19_Mild / Disease, condition lineage and cell class | 8.51e-06 | 199 | 162 | 7 | 46f31aef26c3da7608082f750d743ad54adbc51a | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.36e-05 | 142 | 162 | 6 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.78e-05 | 149 | 162 | 6 | 2cd860b96ed4be4d26844085d464961c1418054a | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-05 | 153 | 162 | 6 | 8cc2667213bfac37545bb63181e88ef1f1834413 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-05 | 153 | 162 | 6 | 596bb7cfd1c713708ce73df30d890a0233eae7f7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.23e-05 | 155 | 162 | 6 | 881422c57d230c0e2e5f9098ab888caa94ca61aa | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 160 | 162 | 6 | 7217730ae14840b935b3bf9aa49becbcbcd8a682 | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 160 | 162 | 6 | 317ef81460c1a31b51119a6309b11be6a8d4ea3e | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 160 | 162 | 6 | e6191240c93da34fc4431a35ef496edf323cb41e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 3.06e-05 | 164 | 162 | 6 | 3b6a32ba53d05f6818fe950ac426f489383b645a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.17e-05 | 165 | 162 | 6 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 167 | 162 | 6 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.62e-05 | 169 | 162 | 6 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-5|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.62e-05 | 169 | 162 | 6 | 9c4e83fe8225d16173a103bf5a57b17d623be923 | |
| ToppCell | Control-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 3.74e-05 | 170 | 162 | 6 | fb05f49b7113470995b3c16683c54dc1a660b73a | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.74e-05 | 170 | 162 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 4.13e-05 | 173 | 162 | 6 | 5645a3b1e805c71d5d65fc8e4edc4e13208063fc | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.13e-05 | 173 | 162 | 6 | 67c342295b8a06ce38e081ba74478c568917a396 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.13e-05 | 173 | 162 | 6 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Plasma_cells-IgM_plasma_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.13e-05 | 173 | 162 | 6 | 77e2b2e66c89984769f2800bdeeab42f9cf9fc46 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 4.26e-05 | 174 | 162 | 6 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.40e-05 | 175 | 162 | 6 | 019ea30ac55748463d7917abf3d3f0e804189bfd | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.40e-05 | 175 | 162 | 6 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 175 | 162 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 175 | 162 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells|bone_marrow / Manually curated celltypes from each tissue | 4.40e-05 | 175 | 162 | 6 | 51301f3f44d3e88397f367cedd1e2abaa2be4c6f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-05 | 175 | 162 | 6 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | IPF-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 4.54e-05 | 176 | 162 | 6 | cc0cab6487df6867b529596ec94f55d31aa6ca36 | |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | 4.54e-05 | 176 | 162 | 6 | 4b4416f342b732d2cc60133838728880326257d8 | |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | 4.54e-05 | 176 | 162 | 6 | d895a6b295cd649273ff80ad7785a3e0ae4c728a | |
| ToppCell | IPF-Lymphoid-B_Plasma|IPF / Disease state, Lineage and Cell class | 4.54e-05 | 176 | 162 | 6 | e4f33f6cd140dd4fa3002bcd65ac8005d27865d1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-05 | 177 | 162 | 6 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 2.99e-07 | 171 | 156 | 10 | 5026_UP | |
| Drug | fullerene C60 | EGLN2 UBQLN2 UBQLN4 ASH1L NUP98 SRGAP2 LHX3 PLEKHG2 SRCAP ZHX2 DCTN1 ZFP36 MAP3K1 MAPK8IP3 CCNF PER3 PER2 TRIM28 GPR153 CCNL1 DLX2 BSN MUC4 TNS1 AFF4 PRRC2B AGAP1 PDZD2 PROX1 | 3.30e-07 | 1498 | 156 | 29 | ctd:C069837 |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; HL60; HG-U133A | EGLN2 DOK3 TBC1D2B NUP98 NUP42 TFCP2 SEC23IP MACF1 HCFC1 PRRC2B | 1.15e-06 | 198 | 156 | 10 | 2002_DN |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; PC3; HT_HG-U133A | CACNB2 SPEG ASH1L MINDY2 MAPK8IP3 SETDB1 MCM3AP DLX2 CDC25C SAMD4A | 1.15e-06 | 198 | 156 | 10 | 3745_DN |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.65e-06 | 160 | 156 | 9 | 4404_UP | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.83e-06 | 162 | 156 | 9 | 2658_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 2.13e-06 | 165 | 156 | 9 | 3770_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 4.35e-06 | 180 | 156 | 9 | 4541_DN | |
| Drug | Hycanthone [3105-97-3]; Up 200; 11.2uM; PC3; HT_HG-U133A | 8.67e-06 | 196 | 156 | 9 | 4630_UP | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Up 200; 12uM; PC3; HT_HG-U133A | 9.03e-06 | 197 | 156 | 9 | 7267_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A | 9.03e-06 | 197 | 156 | 9 | 1240_DN | |
| Drug | LY294002; Up 200; 10uM; MCF7; HT_HG-U133A | 9.41e-06 | 198 | 156 | 9 | 5937_UP | |
| Drug | Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A | CACNB2 NCKIPSD LAIR2 MINDY2 MAPK8IP3 MCM3AP CDC25C TNS1 SAMD4A | 9.41e-06 | 198 | 156 | 9 | 4812_UP |
| Drug | Bumetanide [28395-03-1]; Up 200; 11uM; HL60; HT_HG-U133A | 9.79e-06 | 199 | 156 | 9 | 2409_UP | |
| Drug | Etanidazole [22668-01-5]; Down 200; 18.6uM; PC3; HT_HG-U133A | 9.79e-06 | 199 | 156 | 9 | 5730_DN | |
| Drug | tamoxifen citrate; Up 200; 1uM; ssMCF7; HG-U133A | 1.02e-05 | 200 | 156 | 9 | 375_UP | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.02e-05 | 200 | 156 | 9 | 6057_UP | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.31e-05 | 157 | 156 | 8 | 2651_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.50e-05 | 160 | 156 | 8 | 5275_UP | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.64e-05 | 162 | 156 | 8 | 7340_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A | 1.64e-05 | 162 | 156 | 8 | 3771_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.79e-05 | 164 | 156 | 8 | 3963_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.88e-05 | 165 | 156 | 8 | 3851_UP | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.96e-05 | 166 | 156 | 8 | 5826_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.05e-05 | 167 | 156 | 8 | 6047_UP | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 2.14e-05 | 168 | 156 | 8 | 2801_UP | |
| Drug | Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.14e-05 | 168 | 156 | 8 | 4365_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 2.43e-05 | 171 | 156 | 8 | 5247_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 2.64e-05 | 173 | 156 | 8 | 5612_UP | |
| Drug | Thonzonium bromide [553-08-2]; Up 200; 6.8uM; PC3; HT_HG-U133A | 2.64e-05 | 173 | 156 | 8 | 4617_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; PC3; HT_HG-U133A | 2.86e-05 | 175 | 156 | 8 | 4651_UP | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 2.98e-05 | 176 | 156 | 8 | 4827_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.37e-05 | 179 | 156 | 8 | 5086_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.79e-05 | 182 | 156 | 8 | 3887_DN | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.79e-05 | 182 | 156 | 8 | 848_UP | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.94e-05 | 183 | 156 | 8 | 1475_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.09e-05 | 184 | 156 | 8 | 2321_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 4.59e-05 | 187 | 156 | 8 | 6709_UP | |
| Drug | Contact Lens Solutions | 4.66e-05 | 2 | 156 | 2 | ctd:D018639 | |
| Drug | PCI 5002 | RBM15 UBQLN1 NUP98 ZFP36 PPIF EGR1 ZNF408 CCNL1 ELF3 DLX2 GCC1 MED26 POLQ SPTY2D1 AFF4 SAMD4A | 4.71e-05 | 735 | 156 | 16 | ctd:C568608 |
| Drug | resveratrol; Down 200; 50uM; MCF7; HG-U133A | 5.14e-05 | 190 | 156 | 8 | 622_DN | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 5.14e-05 | 190 | 156 | 8 | 1483_UP | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Down 200; 15uM; PC3; HT_HG-U133A | 5.74e-05 | 193 | 156 | 8 | 6677_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 5.95e-05 | 194 | 156 | 8 | 5599_DN | |
| Drug | Tolazamide [1156-19-0]; Up 200; 12.8uM; PC3; HT_HG-U133A | 6.17e-05 | 195 | 156 | 8 | 4003_UP | |
| Drug | monastrol; Up 200; 100uM; MCF7; HG-U133A | 6.39e-05 | 196 | 156 | 8 | 627_UP | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | 6.39e-05 | 196 | 156 | 8 | 7137_UP | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | 6.39e-05 | 196 | 156 | 8 | 4535_UP | |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 6.39e-05 | 196 | 156 | 8 | 3849_UP | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 6.39e-05 | 196 | 156 | 8 | 7335_UP | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 6.63e-05 | 197 | 156 | 8 | 3886_DN | |
| Drug | Fosfosal [6064-83-1]; Up 200; 18.4uM; PC3; HT_HG-U133A | 6.63e-05 | 197 | 156 | 8 | 4239_UP | |
| Drug | Estrone [53-16-7]; Down 200; 14.8uM; HL60; HT_HG-U133A | 6.63e-05 | 197 | 156 | 8 | 3071_DN | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; HL60; HG-U133A | 6.63e-05 | 197 | 156 | 8 | 1600_DN | |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; PC3; HT_HG-U133A | 6.63e-05 | 197 | 156 | 8 | 4545_UP | |
| Drug | 5707885; Down 200; 50uM; MCF7; HT_HG-U133A | 6.63e-05 | 197 | 156 | 8 | 6385_DN | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 6.87e-05 | 198 | 156 | 8 | 5013_DN | |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; HL60; HG-U133A | 6.87e-05 | 198 | 156 | 8 | 1595_DN | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; PC3; HG-U133A | 6.87e-05 | 198 | 156 | 8 | 1940_DN | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; HL60; HG-U133A | 7.11e-05 | 199 | 156 | 8 | 1989_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 7.11e-05 | 199 | 156 | 8 | 5309_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 7.11e-05 | 199 | 156 | 8 | 6492_DN | |
| Drug | PF-01378883-00 [351320-41-7]; Down 200; 10uM; PC3; HT_HG-U133A | 7.11e-05 | 199 | 156 | 8 | 6368_DN | |
| Drug | Praziquantel [55268-74-1]; Up 200; 12.8uM; HL60; HG-U133A | 7.11e-05 | 199 | 156 | 8 | 1572_UP | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HG-U133A | 7.11e-05 | 199 | 156 | 8 | 1960_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A | 7.11e-05 | 199 | 156 | 8 | 4313_DN | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; HL60; HG-U133A | 7.37e-05 | 200 | 156 | 8 | 2039_DN | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HG-U133A | 7.37e-05 | 200 | 156 | 8 | 1896_DN | |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; HL60; HT_HG-U133A | 7.37e-05 | 200 | 156 | 8 | 6128_UP | |
| Drug | butirosin A from Bacillus vitellinus; Down 200; 10uM; PC3; HG-U133A | 7.37e-05 | 200 | 156 | 8 | 666_DN | |
| Drug | Azacyclonol [115-46-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 9.48e-05 | 154 | 156 | 7 | 1520_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A | 1.16e-04 | 159 | 156 | 7 | 4328_UP | |
| Drug | Cosopt | 1.26e-04 | 341 | 156 | 10 | CID000003154 | |
| Drug | Boric Acids | 1.39e-04 | 3 | 156 | 2 | ctd:D001888 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.40e-04 | 164 | 156 | 7 | 3852_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.51e-04 | 166 | 156 | 7 | 3290_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; PC3; HT_HG-U133A | 1.57e-04 | 167 | 156 | 7 | 6680_UP | |
| Drug | Puromycin dihydrochloride [58-58-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.63e-04 | 168 | 156 | 7 | 5310_UP | |
| Drug | Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.75e-04 | 170 | 156 | 7 | 6051_UP | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.75e-04 | 170 | 156 | 7 | 965_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.75e-04 | 170 | 156 | 7 | 4680_UP | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.82e-04 | 171 | 156 | 7 | 7535_DN | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.82e-04 | 171 | 156 | 7 | 3318_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 2.02e-04 | 174 | 156 | 7 | 6048_UP | |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.09e-04 | 175 | 156 | 7 | 3873_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.09e-04 | 175 | 156 | 7 | 1058_DN | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.09e-04 | 175 | 156 | 7 | 3295_UP | |
| Drug | 1,2,5,6-dibenzanthracene | ZNF536 GATA2 IRS1 NUP58 ZCCHC2 TRIM24 TFCP2 ZNF503 CCNF SP8 PER3 PER2 EGR1 CLMN TACC3 MAP4K4 | 2.11e-04 | 837 | 156 | 16 | ctd:C026486 |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.17e-04 | 176 | 156 | 7 | 5291_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.17e-04 | 176 | 156 | 7 | 1212_DN | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.32e-04 | 178 | 156 | 7 | 6220_UP | |
| Drug | L0074 | 2.39e-04 | 18 | 156 | 3 | CID005360046 | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 2.40e-04 | 179 | 156 | 7 | 2656_UP | |
| Drug | Withaferin A [5119-48-2]; Up 200; 1uM; PC3; HT_HG-U133A | 2.57e-04 | 181 | 156 | 7 | 3819_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.57e-04 | 181 | 156 | 7 | 6951_DN | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.57e-04 | 181 | 156 | 7 | 5419_DN | |
| Drug | 0175029-0000 [211245-78-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.84e-04 | 184 | 156 | 7 | 4713_DN | |
| Drug | Pimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.03e-04 | 186 | 156 | 7 | 3178_UP | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 3.03e-04 | 186 | 156 | 7 | 5000_DN | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; PC3; HT_HG-U133A | 3.13e-04 | 187 | 156 | 7 | 5116_UP | |
| Disease | amyotrophic lateral sclerosis type 15 (implicated_via_orthology) | 1.34e-07 | 3 | 152 | 3 | DOID:0060206 (implicated_via_orthology) | |
| Disease | cortical thickness | ZNF536 STON1 SMARCAL1 ROR1 NCKAP5 SRGAP2 MLLT10 RREB1 MINDY2 MAP3K1 MAPK8IP3 SP8 NAV3 NAV2 MACF1 TMEM108 TACC3 TNS1 AGAP1 PDZD2 | 1.23e-06 | 1113 | 152 | 20 | EFO_0004840 |
| Disease | neuroimaging measurement | CACNB2 CELF4 ROR1 NCKAP5 MLLT10 RREB1 ZHX2 POM121C TFCP2 MAP3K1 MAPK8IP3 SP8 NAV3 NAV2 MACF1 TACC3 TNS1 AGAP1 | 1.06e-05 | 1069 | 152 | 18 | EFO_0004346 |
| Disease | amnestic disorder (implicated_via_orthology) | 1.10e-05 | 9 | 152 | 3 | DOID:10914 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | CACNB2 ZNF536 ZEB1 GRIA1 MLLT10 ZCCHC2 RREB1 DNAJC6 MAP3K1 PPIF MAPK8IP3 LATS1 CAMKV CCNL1 MACF1 IRS2 BSN MAP4K4 AFF4 | 1.51e-05 | 1206 | 152 | 19 | EFO_0004458 |
| Disease | frontotemporal dementia (implicated_via_orthology) | 2.85e-05 | 12 | 152 | 3 | DOID:9255 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | CACNB2 ROR1 NCKAP5 MLLT10 RREB1 MAP3K1 LATS1 NAV3 NAV2 MACF1 TACC3 TNS1 | 2.99e-05 | 550 | 152 | 12 | EFO_0004346, EFO_0004464 |
| Disease | Advanced Sleep-Phase Syndrome, Familial | 7.88e-05 | 3 | 152 | 2 | C1858496 | |
| Disease | Pitt-Hopkins syndrome (implicated_via_orthology) | 7.88e-05 | 3 | 152 | 2 | DOID:0060488 (implicated_via_orthology) | |
| Disease | Acute myeloid leukemia | 8.64e-05 | 17 | 152 | 3 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 8.64e-05 | 17 | 152 | 3 | 601626 | |
| Disease | calcium measurement | STXBP5L ATXN7L1 TBC1D2B CASR ZCCHC2 RREB1 MACF1 IRS2 KIF5A POLQ MUC1 PARM1 | 1.06e-04 | 628 | 152 | 12 | EFO_0004838 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.09e-04 | 145 | 152 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.20e-04 | 49 | 152 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | advanced sleep phase syndrome (is_implicated_in) | 1.57e-04 | 4 | 152 | 2 | DOID:0050628 (is_implicated_in) | |
| Disease | white matter microstructure measurement | 2.00e-04 | 390 | 152 | 9 | EFO_0005674 | |
| Disease | Myelodysplastic syndrome | 2.61e-04 | 5 | 152 | 2 | cv:C3463824 | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.61e-04 | 5 | 152 | 2 | 614286 | |
| Disease | Myeloid Leukemia, Chronic | 4.44e-04 | 29 | 152 | 3 | C0023473 | |
| Disease | Malignant neoplasm of breast | EVL KRT5 ZEB1 SMARCAL1 ROR1 YY2 NUP98 NUP214 MAP3K1 PER3 PER2 MACF1 BOD1L1 FCRL5 TNS1 | 4.54e-04 | 1074 | 152 | 15 | C0006142 |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 4.91e-04 | 30 | 152 | 3 | DOID:332 (implicated_via_orthology) | |
| Disease | vital capacity | INTS12 STON1 LHX3 MLLT10 RREB1 ZHX2 TRIM24 MAP3K1 TRIM66 EDAR RPRD2 MUC1 TNS1 AGAP1 SAMD4A PDZD2 | 6.66e-04 | 1236 | 152 | 16 | EFO_0004312 |
| Disease | common bile duct neoplasm (is_marker_for) | 7.23e-04 | 8 | 152 | 2 | DOID:4608 (is_marker_for) | |
| Disease | osteoarthritis, spine, body mass index | 7.23e-04 | 8 | 152 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 9.48e-04 | 84 | 152 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | thalamus volume | 9.91e-04 | 85 | 152 | 4 | EFO_0006935 | |
| Disease | information processing speed | 9.91e-04 | 85 | 152 | 4 | EFO_0004363 | |
| Disease | IGF-1 measurement | 1.00e-03 | 488 | 152 | 9 | EFO_0004627 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.04e-03 | 148 | 152 | 5 | C0279702 | |
| Disease | dry eye syndrome (is_marker_for) | 1.15e-03 | 10 | 152 | 2 | DOID:10140 (is_marker_for) | |
| Disease | allergic conjunctivitis (is_marker_for) | 1.15e-03 | 10 | 152 | 2 | DOID:11204 (is_marker_for) | |
| Disease | Liver carcinoma | 1.31e-03 | 507 | 152 | 9 | C2239176 | |
| Disease | mean fractional anisotropy measurement | 1.50e-03 | 95 | 152 | 4 | EFO_0008399 | |
| Disease | cortical surface area measurement | ZNF536 STON1 ROR1 NCKAP5 RREB1 MAP3K1 SP8 NAV3 NAV2 MACF1 TACC3 CDC25C MAP4K4 TNS1 AGAP1 PDZD2 | 1.61e-03 | 1345 | 152 | 16 | EFO_0010736 |
| Disease | iron biomarker measurement, serum iron measurement | 1.68e-03 | 12 | 152 | 2 | EFO_0004461, EFO_0006332 | |
| Disease | pulmonary function measurement, forced expiratory volume, smoking behaviour measurement | 1.68e-03 | 12 | 152 | 2 | EFO_0003892, EFO_0004314, EFO_0005671 | |
| Disease | motor neuron disease (implicated_via_orthology) | 1.68e-03 | 12 | 152 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | status epilepticus (biomarker_via_orthology) | 1.81e-03 | 100 | 152 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 1.98e-03 | 13 | 152 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | chronotype measurement | ZNF536 STON1 ZCCHC2 PER3 PER2 CAMKV NAV3 RPRD2 TMEM108 BSN MUC1 ADGRL3 | 2.11e-03 | 882 | 152 | 12 | EFO_0008328 |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.16e-03 | 105 | 152 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | insomnia measurement | 2.17e-03 | 443 | 152 | 8 | EFO_0007876 | |
| Disease | silicosis (biomarker_via_orthology) | 2.30e-03 | 14 | 152 | 2 | DOID:10325 (biomarker_via_orthology) | |
| Disease | inflammatory biomarker measurement, YKL40 measurement | 2.33e-03 | 51 | 152 | 3 | EFO_0004869, EFO_0004872 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.65e-03 | 15 | 152 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | forced expiratory volume | INTS12 STON1 LHX3 ZHX2 PIAS1 MAP3K1 EDAR RPRD2 MUC1 TNS1 PRRC2B | 2.67e-03 | 789 | 152 | 11 | EFO_0004314 |
| Disease | breast cancer (is_marker_for) | 2.76e-03 | 185 | 152 | 5 | DOID:1612 (is_marker_for) | |
| Disease | serum gamma-glutamyl transferase measurement | ZEB1 FAM53A SIPA1L3 ASH1L RREB1 POM121C ZNRF2 PPIF POM121 EDAR NAV2 PROX1 | 2.82e-03 | 914 | 152 | 12 | EFO_0004532 |
| Disease | HOMA-B | 2.89e-03 | 55 | 152 | 3 | EFO_0004469 | |
| Disease | Withdrawal Symptoms | 3.36e-03 | 58 | 152 | 3 | C0087169 | |
| Disease | Amyotrophic Lateral Sclerosis | 3.36e-03 | 58 | 152 | 3 | C0002736 | |
| Disease | Drug Withdrawal Symptoms | 3.36e-03 | 58 | 152 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 3.36e-03 | 58 | 152 | 3 | C0038587 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 3.39e-03 | 194 | 152 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | Bipolar Disorder | 3.41e-03 | 477 | 152 | 8 | C0005586 | |
| Disease | Amyotrophic lateral sclerosis | 3.41e-03 | 17 | 152 | 2 | cv:C0002736 | |
| Disease | otitis media (biomarker_via_orthology) | 3.41e-03 | 17 | 152 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.41e-03 | 17 | 152 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | pain | 3.54e-03 | 196 | 152 | 5 | EFO_0003843 | |
| Disease | schizophrenia, sex interaction measurement | 3.70e-03 | 60 | 152 | 3 | EFO_0008343, MONDO_0005090 | |
| Disease | neuroimaging measurement, brain volume measurement | 3.75e-03 | 286 | 152 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | body fat percentage | 3.91e-03 | 488 | 152 | 8 | EFO_0007800 | |
| Disease | Acute Myeloid Leukemia, M1 | 4.05e-03 | 125 | 152 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 4.05e-03 | 125 | 152 | 4 | C1879321 | |
| Disease | facial asymmetry measurement | 4.26e-03 | 19 | 152 | 2 | EFO_0009751 | |
| Disease | Juvenile Myelomonocytic Leukemia | 4.26e-03 | 19 | 152 | 2 | C0349639 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.41e-03 | 128 | 152 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.41e-03 | 128 | 152 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.41e-03 | 128 | 152 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 4.41e-03 | 128 | 152 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.41e-03 | 128 | 152 | 4 | C0007134 | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.44e-03 | 64 | 152 | 3 | DOID:4947 (is_marker_for) | |
| Disease | brain connectivity measurement | 4.82e-03 | 400 | 152 | 7 | EFO_0005210 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QAGSGSAGTSPGSSA | 6 | Q8NHY2 | |
| SSGTSGGQSPVSSDA | 1111 | Q9NR48 | |
| GGGSLSDYSSSVPST | 271 | Q9UPQ3 | |
| ASTGVAGASSSLGPS | 156 | Q14203 | |
| GSSELSSSVSPGTGR | 21 | Q9UJW3 | |
| SEGISAGSPTSGSTH | 946 | Q8IZF6 | |
| SLGGSTGSTPSSSIS | 901 | P41180 | |
| PAVQASGGSGSSSES | 476 | P51816 | |
| MSSSGGAPGASASSA | 1 | Q9UGQ2 | |
| SGSRTPGRYSTGSQS | 1136 | Q9HAR2 | |
| AAPSGSGNGSGSSSS | 406 | Q9BZP6 | |
| PGSSDVSTAGTGASR | 191 | P78545 | |
| SSAAPSAGGSSSGTT | 16 | Q9UK58 | |
| GAGSSGSSPSSAASA | 261 | Q07687 | |
| SGPAQDSLLGSSGSS | 366 | Q9ULK2 | |
| DGESGSPSSSSSGSL | 196 | Q8IXJ9 | |
| LSPGNSGNYSSGASS | 1061 | Q9UHB7 | |
| GGNSSSSLGDIVPSS | 201 | Q08289 | |
| GGRSAASSSVSFSPG | 71 | Q6P1R3 | |
| SVSGSVPSSGSSGRE | 136 | P54725 | |
| YSSPSTKNSSGGGES | 126 | Q96T37 | |
| NSGTSGPSGSTTSKT | 406 | Q96CB8 | |
| APQALSGSSSSTAGS | 676 | Q9HCC9 | |
| STGEPSSGQESAGSA | 1551 | P51610 | |
| TGPSGATSQGTFTLD | 9371 | Q8WXI7 | |
| SSSGASGTTPSGSEG | 806 | Q99102 | |
| GSGSSSGSSNSGSQP | 676 | O95819 | |
| AGTTTGLFGSSPATS | 221 | P52948 | |
| STTSAPSFGTTSGGL | 376 | P52948 | |
| GTSFSSSSPGLASAG | 251 | Q7Z434 | |
| GGASTSVLDGPSTSS | 706 | Q96JG8 | |
| ESGQSSAAATPSTTG | 256 | Q9UPT6 | |
| DRFSGSGSGTDFTLT | 81 | A0A0C4DH25 | |
| TGGSAAPSSYTNGSI | 391 | O95835 | |
| SQSFSGVPSRFSGSG | 71 | A0A0C4DH24 | |
| SSSAGDQSGSPTAYG | 216 | Q9NPF0 | |
| SGGSRSFSTASAITP | 11 | P13647 | |
| ATSGASANFPGTSGS | 151 | Q9UNE0 | |
| QASPSGGAALSSSTA | 51 | Q86X51 | |
| TSGPSSSSVLGNTGF | 96 | O60318 | |
| LSSHSPGSGSSTTQG | 61 | P15941 | |
| VSFSTPTSSDSSGGR | 1321 | Q9UPA5 | |
| AAGAPEGSGSNSSSS | 51 | P18146 | |
| DSSESTGSGGPVSAR | 806 | O15055 | |
| GSESSPATTGALSTG | 961 | P56645 | |
| TLGSSSAPSGGEASF | 606 | Q96RD9 | |
| SQSISGVPSRFSGSG | 71 | A0A0A0MT36 | |
| PAGGFFNSSSSSGDS | 86 | Q7Z5P9 | |
| SSSGTSTGASNTPGA | 2021 | Q7Z5P9 | |
| STGASNTPGATGSST | 2026 | Q7Z5P9 | |
| TGSSTGQTDTSGPSA | 2036 | Q7Z5P9 | |
| SAEGSGTTGPSSRES | 2136 | Q7Z5P9 | |
| TAGTSSGGHSTTSPS | 3116 | Q7Z5P9 | |
| GTTGSSARSGTSIPS | 3266 | Q7Z5P9 | |
| GSSNTGATASPGGSA | 6601 | Q7Z5P9 | |
| GSFSTAATTSPGASG | 6966 | Q7Z5P9 | |
| TSSGASGITRAGPTS | 7256 | Q7Z5P9 | |
| FRTGNTPGSTGVTSS | 8046 | Q7Z5P9 | |
| ASAARSPSSQTGDSG | 1436 | O15018 | |
| GSLESPSSGTGSMGS | 1286 | Q8IVL0 | |
| ASGGSSPSGTSKSDA | 241 | Q9UI08 | |
| TRPTTLGSSQFSGSG | 36 | Q99081 | |
| GGSTSSFLSSPSESS | 581 | Q6NV75 | |
| PSASSGNETTFSGGG | 1151 | Q7LBC6 | |
| AGDTSNSSSPASTGA | 3411 | O94854 | |
| NPFSSASGGFGSTAT | 1901 | P35658 | |
| QLAFPGTGEASSGST | 176 | Q7L591 | |
| GTGEASSGSTDAQSP | 181 | Q7L591 | |
| LAGNGPSSDLSTGSS | 361 | Q9UBR4 | |
| PGSGRSTSVSSASSY | 371 | Q3SXY7 | |
| NTDPSPSGFSSTSGG | 101 | Q6UWI2 | |
| RSSASVSGSPSDGGF | 411 | P35568 | |
| SGSPESFASSLDGSG | 186 | O95402 | |
| FSSTREEGSSGSGPS | 6 | P30307 | |
| SSAPSAFTTVGGSSG | 66 | Q8TDS5 | |
| GSSPAFGAAASTSSG | 266 | O15504 | |
| AGQSGSTATSTPFTG | 1111 | A8CG34 | |
| GSSLSFGASSAPAQG | 1176 | A8CG34 | |
| AGQSGSTATSTPFAG | 716 | A6NF01 | |
| GSSLSFGASSAPAQG | 781 | A6NF01 | |
| GAPSGTSGTAAATAA | 6 | Q7Z3B4 | |
| AGQSGSTATSTPFAG | 1131 | Q96HA1 | |
| GSSLSFGASSAPAQG | 1196 | Q96HA1 | |
| AATSPGSLSSSSGHG | 441 | Q9Y4H2 | |
| PETGTAGGSSTASYS | 2476 | Q8NFC6 | |
| STTGAASPASSSAGG | 186 | P23769 | |
| SESGVSSSSGDGPFA | 136 | Q96CN9 | |
| SATDTATPGAAGGAT | 341 | Q8NCB2 | |
| PSTFCGDSGFSGSSS | 131 | Q96B18 | |
| STASPTSSVDGGLGA | 706 | P41002 | |
| DSSSGNSTALTSGPA | 156 | Q6P531 | |
| SGSGGDSSASPQFLS | 21 | O75417 | |
| GSKSAATSPTGSSHG | 651 | O75061 | |
| GGGSVASPTSSSGSS | 296 | Q9Y5N1 | |
| SSEAGGSGPSSSIAI | 836 | Q9P267 | |
| TSSGATSSGGPLASY | 976 | Q12840 | |
| DRFSGSGSGTDFTLT | 81 | P01619 | |
| ATSIPARFSGSGSGT | 76 | A0A075B6H7 | |
| ARFSGSGSGTDFTLT | 81 | A0A075B6H7 | |
| DRFSGSGSGTDFTLT | 86 | P06312 | |
| SSGGSSTNSLTGSRP | 181 | Q5T9C2 | |
| EASAGSGTPRATATS | 56 | Q96KS0 | |
| TSTLPRNSGAGASSG | 856 | P42261 | |
| LSTSGSSFDNGPSSA | 1131 | Q5VT52 | |
| GTFGSEHSASPSQGS | 336 | Q9UPN6 | |
| FASGSPAPSSGGNTS | 301 | Q9P1A2 | |
| SSAGTVPGTEASGFD | 136 | Q6ISS4 | |
| KPSGSLSAGFGSSST | 536 | Q9BVL2 | |
| ESTGNSGGSSGSSPS | 601 | Q13233 | |
| GSSPSGGATSGSSQT | 611 | Q13233 | |
| SSSASSSSVVFPGGG | 401 | Q6ZN04 | |
| AGSEEPSSAGGLSSS | 146 | Q8NBR6 | |
| RPSGAATTTAAGTSA | 416 | Q86TM6 | |
| TAASATASGPGSGSA | 431 | Q86TM6 | |
| DASPAFGSGSSSESG | 131 | Q9Y6A5 | |
| SAGGAPGGSASSSST | 16 | Q5TCX8 | |
| SLGSSGSFSSQHGSP | 1351 | O14513 | |
| IPDRFSGSSSGNTAS | 76 | P01714 | |
| SGVPDRFSGSSSGAD | 81 | A0A075B6I1 | |
| SSRAESSSGGGTVPS | 546 | Q68EM7 | |
| GTEPSFQASGLSSTG | 106 | Q92786 | |
| LDSPSGSGVLSSGSS | 1361 | Q8IVL1 | |
| FDPGSASGTSGSSSQ | 906 | Q9NZC9 | |
| GPSSTGASGQAKSSS | 341 | Q9NWH9 | |
| YSSGSSTPTGLAGGS | 1381 | O60292 | |
| SLGGSGGSSTSAPTT | 326 | Q6ZUB0 | |
| STGALGTTGNPSASS | 1066 | Q6ZUB1 | |
| GSAFTGGTVSSSTPS | 31 | Q13516 | |
| SKGSGDPSSSSSSGN | 31 | P30405 | |
| GGASTSSSGTNLLFS | 11 | Q9Y6Y8 | |
| GGSTSLPTTNGSSSG | 596 | O75925 | |
| SPASSSSPASSGAGG | 31 | Q6ZRS2 | |
| NGSSSSGPERSISGS | 401 | Q68D10 | |
| SPGFSSFPGVDSSSS | 31 | Q6UX06 | |
| PSGGNSVSSGSSVSS | 206 | Q9NZQ3 | |
| DGLTASSPGSGSSSG | 11 | Q9Y2K9 | |
| GSPGSSAFSLTSSSA | 91 | Q8IXZ3 | |
| STSFRPGSVGSGHSS | 491 | Q15047 | |
| GSFSGTPGSVKSSSG | 351 | P55197 | |
| ASLSTNGLGSSPGSA | 16 | Q9BZC1 | |
| LSPGSGGTDSDSSFP | 156 | Q96JQ2 | |
| DSGNPSTTRFTGYGS | 666 | Q9C0B9 | |
| GLSSHTSSTTPSGGN | 751 | Q01973 | |
| SLGGSGGSSTSAPTT | 326 | P0C874 | |
| SDLPSSSSGGANGTA | 21 | Q8NHG8 | |
| PSASSVGSRGSSGSS | 686 | O15164 | |
| DSQGGRAGSSSPSSA | 81 | Q96NJ1 | |
| GLREFPSGSSSTSST | 46 | Q9Y6Q2 | |
| GSEASATSGSSAPGE | 2526 | Q15772 | |
| GASISFNGAPSSSGG | 736 | Q12816 | |
| GSPSSSGSFGGTLST | 901 | Q12816 | |
| GSPCTSTGFGGTLST | 921 | Q12816 | |
| GSPGTSVSFGSALNT | 1011 | Q12816 | |
| GFTGEPSTSTGFSSG | 1346 | Q12816 | |
| SSHSSFSLGEGNGSP | 296 | Q12800 | |
| PGSGPVGSSGSSSTF | 251 | P15923 | |
| PASTGSNTTASDSLG | 1091 | Q92766 | |
| STAPSAGSTAGDSGA | 1056 | Q9H7N4 | |
| FGADTQSGSSGSSPV | 311 | Q9Y458 | |
| QSGSSGSSPVTSSGG | 316 | Q9Y458 | |
| NSTSGSATSNPFGLG | 136 | Q9UMX0 | |
| DGSGASFSSSARGTQ | 286 | Q9H9D4 | |
| GLSSSLTDSSSPGVG | 856 | O75044 | |
| TSTEANPAGSSSSLG | 151 | O15391 | |
| ASGMSSPSGGSTVSF | 1416 | Q9HBL0 | |
| SSGSSLGGSDSPVFE | 286 | P26651 | |
| GSRNSSTGDGAPSSA | 231 | Q5JSZ5 | |
| SLQSPGSRSSSAGGT | 421 | Q2KHR2 | |
| STPATSAGGGIFGSS | 1201 | P49790 | |
| SSVSSATGDGNLSPS | 571 | P37275 | |
| SSSDGGDSLQPTGTS | 1201 | O15090 | |
| GSSSGSGPSAPTSSS | 316 | Q96F45 | |
| TTSGPGTGDSDSGIS | 166 | Q9Y6X8 | |
| VAGTSASSPAGSRES | 46 | Q9UIW0 | |
| SGSSSSGLGTVSNSP | 791 | Q9UPP1 | |
| PRGSGSSTSLSTVGS | 46 | Q9H7P9 | |
| EFGGGSGSSPSSSSL | 66 | Q9UMR3 | |
| PFASVGSSSSSGEGT | 291 | Q9UHD9 | |
| GSSSSSGEGTQPSRT | 296 | Q9UHD9 | |
| PETGSSSSSGRTSGS | 766 | O15016 | |
| PSTSGSASSDAGSGS | 121 | Q9NRR5 | |
| SSGDPSSEGTSGSGS | 316 | Q9UPU7 | |
| SGTPGATSSTGFQES | 756 | Q9UP52 | |
| LSPQSSVASSGSGGS | 291 | Q9UPU9 | |
| SASASAAASSPAGGG | 41 | Q13263 | |
| FTSQGGTPDATAASG | 291 | Q6UXF1 | |
| RPSSASGGFVDSSEG | 186 | Q6NSI3 | |
| ERTLSPSSGYSSQSG | 516 | Q9P206 | |
| GEESTTFPSSSGSTG | 1381 | Q9UKN1 | |
| GEESTTFPSSSGSTG | 4021 | Q9UKN1 |